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SUMMARY
The aim of this thesis was to study agonist-induced contractions in smooth 
muscle. The majority of the work was undertaken on rat anococcygeus, 
although some has been performed on guinea pig portal vein longitudinal 
muscle. The agonists which were examined (noradrenaline, phenylephrine and 
acetylcholine) all cause contraction in rat anococcygeus. They are thought to 
have their effect mediated by a G-protein which in turn stimulates the 
phosphatidylinositol cycle and promotes contraction. Work was carried out 
therefore, to analyse the effect of receptor activation at two levels: (a) the
G-protein; and (b) the phosphatidylinositol cycle. To examine the intracellular 
effects of receptor activation the muscle was permeabilized. Part of this thesis 
comprises an investigation into the effectiveness of the three putative 
permeabilizing techniques.
ANALYSIS OF THREE DIFFERENT PERMEABILIZATION TECHNIQUES 
The three permeabilization techniques examined were:
(a) saponin-treatment; (b) EGTA- treatment; and (c) alpha-toxin-treatment. To
analyse the effectiveness of each treatment several tests were carried out and
the behaviour of the permeabilized smooth muscle after the three different
treatments was compared with that of an intact muscle. The muscles were
examined to see: (i) if they contracted readily to calcium; (ii) if they produced
rigor crossbridges when ATP and CrP were removed from the bathing medium;
(iii) how they responded when two factors known to have a direct effect on the 
contractile proteins, cyclic AMP and inorganic phosphate, were added to the 
bathing medium; and (iv) how they responded to the application of 
noradrenaline at a low calcium concentration.
It was found that calcium-activated force decayed with time in saponin- 
and alpha-toxin-treated muscle. Possible mechanisms for the decay were 
examined. These included: (a) loss of calmodulin; (b) reduced or increased 
ionic strength; and (c) reduced or increased pH. These were all examined in 
saponin-treated muscle. The effect of lowering ionic strength was examined in 
toxin-treated muscle.
RECEPTOR ACTIVATION AND CONTRACTION
Once a suitable permeabilization technique had been established, further 
experimentation was undertaken to examine the effect of receptor activation on 
contraction in intact and permeabilized muscle. The permeabilization technique 
adopted was alpha-toxin treatment. Originally it had been hoped that this 
method would allow the analysis of receptor activation by noradrenaline and 
acetylcholine. However, it was found that alpha-toxin-treated rat anococcygeus 
muscle was unable to contract in response to acetylcholine. Possible reasons for
r
this/is examined in Chapter 4.
(a) G-protein
Kitazawa et al (1989) had already reported that GTP had to be included 
in the bathing medium before phenylephrine could produce a contraction in
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alpha-toxin permeabilized guinea pig portal vein. This led these workers to 
conclude that a G-protein was involved in receptor activation. The rest of 
Chapter 4 aims to assess the involvement of G-proteins in receptor activation 
in alpha-toxin-treated rat anococcygeus and guinea pig portal vein. Receptor 
activation was examined by looking at its effect on calcium release and 
calcium-activated force. The involvement of G-proteins was examined by using 
GTP, GTP-7 -S (a non-hydrolysable analogue of GTP) and GDP7 8 -S (a 
non-hydrolysable analogue of GDP).
A striking feature of the noradrenaline-activated contractions in both 
tissues was that their amplitude decayed upon repeated exposure. Several 
factors were examined to ascertain the cause of this decay. These included 
examining the effect of GTP on the decay, the accessibility of the calcium store 
and the sensitivity of the calcium store to Ins(l,4,5)P3  before and after the decay 
in noradrenaline-activated force.
(b) phosphatidylinositol cycle
The fifth chapter attempts to assess the role of the phosphatidylinositol 
cycle in receptor activation. This was examined by chronically treating rats with 
lithium chloride which is known to block the phosphatases which normally are 
responsible for the breakdown of Ins(l,4,5)Pj. This blockade eventually causes 
the rundown of inositol within the cell and, therefore, eventually of 
PtdIns(4,5)P2, the precursor of Ins(l,4,5)P3  and of diacylglycerol (DG).
The effects of chronic lithium treatment of rats on (i) the concentration 
response curves to different agonists; and (ii) the intracellular component
XV
produced by different agonists were examined in intact anococcygeus muscle. 
In the second set of experiments, chronic lithium treatment was undertaken at 
the same time as the animals were being given myo-inositol in their drinking 
water. The concentration response curves and the intracellular component in 
these tissues were compared with those form chronic lithium treated animals to 
see whether the inclusion of myo-inositol in the treatment was able to prevent 
the effect of lithium. Lithium was found to depress the response to 
noradrenaline and to the other agonists. To discover if this was a direct effect 
on the contractile proteins or the calcium store, the acute effects of lithium 
exposure were examined, in alpha-toxin permeabilized anococcygeus muscle 
strips, on caffeine-, calcium- and noradrenaline-activated force. The effect of 
acute myo-inositol and lithium exposure was also examined in each of these 
situations.
It was discovered that all three permeabilizing treatments were effective, 
but because of the profound decay in calcium-activated force in saponin-treated 
preparations and the small amount of force produced by EGTA-treated 
preparations these were not used again in the following studies. Instead 
alpha-toxin-treated smooth muscle was used. This type of muscle had the added 
advantage that it retained functional membrane bound receptors. Both rat 
anococcygeus and guinea pig portal vein displayed characteristics which indicated 
that adrenoreceptor activation is mediated through a G-protein. However, in 
rat anococcygeus there appeared to be some other process functioning which 
to some extent masked the involvement of GTP. No concrete conclusions can
be drawn from the LiCl experiments, although the results tentatively suggest 
that, if LiCl does indeed block the Ptdlns cycle, NA at least is linked to this 
cycle to promote contraction.
CHAPTER 1
GENERAL INTRODUCTION
Smooth muscle is widespread throughout the body of vertebrates and its 
contractile activity is vital for normal functioning of the body. The contractile 
parts of the walls of hollow vessels and cavities, such as blood vessels, the 
alimentary canal and the urinogenital tract, are formed from layers of smooth 
muscle cells which propel, mix and retain the contents. Elsewhere smooth 
muscle is less intimately associated with other tissues and their contraction tends 
to move one structure relative to another. These include ciliary muscles and 
nictating membranes of the eye, pilo-erector muscles of the skin and muscle 
which is attached at one end to bone, for example anococcygeus.
Smooth muscle varies widely in its pattern of activity and this is associated 
with the muscle’s position and function. For example, at one extreme, a 
continuous maintained activity may be required of the muscle, as in the iris, 
blood vessels or ureter; whereas at the other extreme, occasional bursts of 
activity occurs in muscle involved in defaecation or pregnancy. Again, tissue 
such as the urinary bladder or iris contract as a unit, whereas, in the ureter or 
intestine, waves of contraction pass from one end to the other. Localised 
contraction of sphincters and arterioles also occur. The activity of any muscle 
depends on a number of factors, including the properties of the individual 
smooth muscle cells, the interactions between cells and the influence of external 
agents such as nerves, hormones and the physical environment.
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Hormones and neurotransmitters exert their action on smooth muscle cells 
by reacting with specific targets on the cell membrane, the receptors. The 
question of how these membrane events are coupled to the contractile response 
has been one of the most intriguing problems in smooth muscle research in 
recent years. As in skeletal and cardiac muscle, excitation-contraction coupling 
involves the release and entry of calcium ions into the cytoplasm. However, the 
rise in [Ca2+] promotes an increase in force in a very different manner from 
that in skeletal and cardiac muscle. Calmodulin is generally accepted to be the 
calcium receptor and with Myosin Light Chain Kinase (MLCK) activates tension. 
The details of this mechanism will be discussed later. This chapter will deal 
with:
( 1 ) the basic types of smooth muscle;
(2 ) the diversity of receptors;
(3) the mechanisms of calcium release and entry;
(4) the site of the stores of intracellular calcium; and
(5) mechanism of force production in smooth muscle.
SMOOTH MUSCLE DIVERSITY
Smooth muscle can be broadly divided into three categories on the basis 
of its inherent plasma membrane electrical activity and its electrical response to 
stimulation. The categories are:
(a) Spontaneously active, highly excitable muscle;
(b) Quiescent, but highly excitable muscle;
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(c) Quiescent, poorly excitable muscle (reviewed by Creed, 1979; Bulbring & 
Tomita, 1987).
Smooth muscle can also be divided on the basis of the type of contraction 
produced by the muscle, that is, whether it is either phasic or tonic. Phasic 
contractions are short lived and usually produced in spontaneously active and 
highly excitable muscles in response to an action potential. These phasic 
contractions can be fused together to produce a maintained contraction or waves 
of contraction and relaxation. Examples of muscles which produce this type of 
contraction are taenia coli (Shimo & Holland, 1966), intestinal smooth muscle 
(Kuriyama & Suzuki, 1975), stomach (Shino, 1976), myometrium (Gabella, 1978), 
portal vein (Gabella, 1978), ureter (Sunano, 1976) and bladder (Sunano & 
Miyazaki, 1975). Tonic contractions are slower to form than phasic contractions 
and are not always preceded by an action potential. These contractions are 
maintained. They are, therefore, more usually found in quiescent, poorly 
excitable muscles e.g. trachea (Kirkpatrick, 1975) aorta (Bohr, 1963), rabbit ear 
artery (Bevan & Waterson, 1971) and rat anococcygeus (Gillespie, 1980).
(a) Spontaneously active, highly excitable muscles: Examples of muscles 
included in this group are the taenia coli, the small and large intestine, the 
myometrium, bladder and the portal vein. These muscles have all been shown 
to have spontaneous action potentials (Bulbring, 1954; Nagai & Prosser, 1963; 
Kuriyama 1967; Kuriyama & Mekata; 1971). These are mostly spike-like, but 
can have a plateau. They may occur in bursts or at regular intervals and 
propogate along the tissue at conduction velocities of 10-80mm/s. This activity
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originates within the muscle and can spread along the muscle length. 
Spontaneous activity arises from simultaneous depolarisation of many cells. The 
pattern of these depolarisations, called slow waves or pacemaker potentials, 
varies in different smooth muscles. However, the basic mechanism appears to 
involve an unstable membrane potential. Transmitters released by nerves act 
on a large number of cells and modify the basic activity, increasing or decreasing 
spike frequency.
In summary, these muscles have an unstable membrane potential and give 
rise to all-or-none action potential which produce phasic contraction. The action 
potential is able to propagate throughout the muscle via ot low-resistance 
pathways between cells and the spontaneous activity can be modified by nerves.
(b) Quiescent, but highly excitable muscle: Examples of muscles included 
in this group are vas deferens and ureter. These muscles are normally 
quiescent, but do occasionally show spontaneous activity and produce phasic 
contractions. The vas deferens is not spontaneously active and normally 
contracts in response to nerve stimulation. This gives rise to excitatory junction 
potentials which sum with each other so that, at a critical value, a spike is 
initiated. In guinea pig vas deferens the spikes are all-or-none with overshoots 
of 20mV (Burnstock & Holman, 1961). In the mouse, however, the spikes are 
graded in amplitude, varying from ’humps’ to overshoots of 5mV (Furness & 
Burnstock, 1969). In these tissues with graded spikes, propagation tends to be 
decremental. This could be due to insufficient current spread between cells or 
to poor electrical excitability of the membrane.
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(c) Quiescent, poorly excitable muscle: Examples of muscle included in this 
group are stomach, trachea, anococcygeus, arteries and veins. This muscle has 
no spontaneous, rhythmic activity. Rat anococcygeus for example has a resting 
membrane potential of -51mV to -75mV and no slow waves or spontaneous 
depolarisation (Creed, Gillespie & Muir, 1975). Furthermore the membrane 
cannot be excited electrically by either intracellular current injection or by 
external polarization. Field stimulation of the excitatory nerves, however, 
produces depolarisation of graded amplitude.
The anococcygeus is densely innervated by adrenergic nerve fibres, but 
close neuromuscular contacts are absent, the minimum separation being 55nm 
(Gillespie & Lullmann-Rauch, 1974). Co-ordinated activity of the whole muscle 
depends on synchronous or sequential nerve discharge. In rat anococcygeus 
spikes are small and rarely seen and contraction apparently occurs in their 
absence. Even with nerve stimulation at less that 1Hz, contraction occurs and 
this is associated with depolarisations of less than 20mV. An action potential 
is, therefore, not essential for activation of the muscle.
Records of the membrane potential suggest that, in arterial and tracheal 
smooth muscle, contraction need not be preceded by a spike. The carotid, main 
pulmonary and ear arteries of the rabbit resemble the rat anococcygeus in being 
quiescent (Mekata & Niu,1972; Casteels et al, 1977). Low concentrations of 
noradrenaline and adrenaline (10/jM) can evoke contractions without 
depolarising the membrane, though at higher concentrations some depolarisation 
occurs. The membrane potentials of tracheal smooth muscle of cattle and dog
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is also stable and there is no spontaneous electrical or mechanical activity 
(Kirkpartrick, 1975; Suzuki, Morita, & Kuriyama, 1976). The mechanical 
response is triggered by a depolarisation of about 5mV. Histamine, 
acetylcholine and nerve stimulation induce contraction and depolarise the 
membrane, sometimes with superimposed slow potential oscillations, but no 
spikes.
Therefore, the rat anococcygeus muscle, certain arteries and tracheal 
smooth muscles cannot be excited directly electrically and have a steady 
membrane potential with no evidence of spontaneous electrical activity. These 
muscles produce tonic contractions.
RECEPTOR DIVERSITY
A ’receptor’ is a protein in the surface membrane which acts as a switch 
turning a biochemical response either on or off within the cell when the 
receptor becomes bound to a ’substrate’. These 'substrates’ are normally 
hormones and/or neurotransmitters and are termed as agonists. Receptors are 
usually named after the agonist or family of agonists which activate them. For 
example the receptors which respond to adrenaline and noradrenaline are 
termed adrenoreceptors; activation of these receptors and the consequences are 
the main concern of this thesis. Adrenoreceptors can be further subdivided into 
two categories a and p. The original subdivision was made by Ahlquist (1948) 
on the basis of the potency of both synthetic and natural compounds to activate 
the receptor. Ahlquist (1948) laid the ground rules for further classification by
6
recognising that receptors should be classified by their pharmacological 
properties rather than their location. This was particularly important because 
these two adrenoreceptor subtypes have inhibitory or excitatory properties 
depending on their location, but the same agonist potency regardless of their 
location.
In the 1960’s it became clear that ^-adrenoreceptors in different tissues 
showed different pharmacological properties. Lands and colleagues (1967) 
proposed that these receptors be further subdivided into and
£2 -adrenoreceptors. ^-Adrenoreceptors were found predominantly in the heart, 
while £2-adrenoreceptors were found predominantly on smooth muscle. 
However, both ^-receptor types can coexist on the same tissue (Minneman, 
Pittman & Molinoff, 1981). ^-Adrenoreceptor subtypes show many similarities 
and only a few differences: both pr  and ^-adrenoreceptors stimulate formation 
of cyclic AMP as their primary mechanism for signal transduction in cells. Very 
few drugs show more than a 20- to 50-fold difference in potency in binding to 
the two different subtypes.
In a similar way during the 1970’s it became clear that a-adrenoreceptors 
in different tissues did not have identical pharmacological properties. Based on 
differences in the potency of phenoxybenzamine in blocking presynaptic 
increases in noradrenaline release and postsynaptic increases in contractility in 
cat spleen, Langer, (1974) proposed that postsynaptic a-adrenoreceptors be 
referred to as a2, and presynaptic receptors be referred to as a2. However, it 
soon became obvious that a2- and a2-adrenoreceptors existed postjunctionally on
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smooth muscle (Docherty, MacDonald & McGrath, 1979 ; Drew & Whiting, 
1979; Timmermans, Kwa & van Zweiten, 1979; Docherty & McGrath, 1980; 
Langer et al, 1980; Starke, 1981; Timmermans & van Zweiten, 1981) and 
activate contraction. It subsequently also became clear that a7-adrenoreceptors 
could exist on presynaptic nerve terminals (Kobinger & Pichler, 1982; Docherty, 
1983; Story, Standford-Starr & Rand, 1985; McDonough, Wetzel & Brown, 
1986). Unlike the ;S-adrenoreceptor subtypes, the a-adrenoreceptor subtypes 
are much less alike. Antagonist selectivities of two or three orders of magnitude 
are often seen between the two a-adrenoreceptor subtypes, whereas a difference 
in potency of one order of magnitude is more likely between the 
/9 -adrenoreceptor subtypes. The a-adrenoreceptors appear also not to use the 
same second messenger system. There is a large body of evidence to suggest 
that a-adrenoreceptors produce their intracellular effects via the phosphatidyl 
inositol cycle (Berridge & Irvine, 1984, 1989) whereas a2-adrenoreceptors are 
thought to work by suppressing cyclic AMP production (Fain & Garcia-Sainz, 
1980; Exton, 1985).
MECHANISMS OF CALCIUM RELEASE AND ENTRY
Once the receptor has been activated it promotes a rise in intracellular 
[Ca2+]. This increase in intracellular [Ca2+] can be brought about by calcium 
entry from the extracellular space, calcium release from the intracellular store 
or by a combination of both. Calcium entry can be brought about by (a) 
membrane depolarisation which opens voltage operated calcium channels
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(VOCs); (b) receptor activation which can directly open calcium channels 
through receptor operated calcium channels (ROCs); and (c) production of 
second messengers, which in turn might open calcium channels (SOCs). Calcium 
release can be brought about by (a) release of intracellular calcium from the 
stores by second messengers and (b) release of calcium from the stores by a 
small increase in the calcium concentration of the cytosol - termed calcium 
induced calcium release (CICR).
Calcium Entry
(a) Voltage Operated Channels: Two types of voltage-operated calcium 
channel have been identified in smooth muscle. These are:
(i) T ’-type channels; these need only a weak deplorisation to open and cause 
short lived inward transient current;
(ii) ’L’-type channels which are characterised by the requirement for a strong 
depolarisation to open and an inward current which decays very slowly 
(Nowychy, Fox & Tsien, 1985).
(b) Receptor Operated Channels: Up until recently, only indirect evidence 
existed to suggest that agonists might cause calcium entry without depolarising 
the membrane. To do so the agonist was thought to act directly on the calcium 
channel causing it to open (Droogmans, Raeymayers & Casteels, 1977; Bolton, 
1979; Meisheri, Hwang & van Breemen, 1981). Recently Benham (Benham & 
Tsien, 1987; Benham, 1989) presented direct evidence that, in voltage clamped 
single cells from the smooth muscle of the rabbit ear arteiy, ATP opens a
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calcium channel in the membrane. There is also a report in the literature that 
acetylcholine opens a non-selective cation channel in isolated cells from guinea 
pig ileum (Inoue & Isenber, 1990)
(c) Second Messenger Operated Channels: There is considerable uncertainty 
concerning the mechanism and control of these channels and there is no direct 
evidence for them in smooth muscle. However, there is evidence in mast cells 
and lymphocytes that cAMP and Ins(l,4,5)P5  can increase channel opening 
(Kuno & Gardener, 1987; Penner, Mathew & Neher, 1988).
There is some evidence to suggest that Ins(l,4,5)Pj might not have a 
direct effect on calcium entry by activating a channel on the plasma membrane, 
but instead release the calcium from the endoplasmic reticulum which then 
causes calcium to enter the cell. This hypothesis is based on work with 
endothelial cells, where calcium entry is preceded by Ins(l,4,5)P5-induced calcium 
release from the endoplasmic reticulum (Hallam, Jacob & Merritt, 1988). There 
is evidence from mouse lacrimal cells that Ins(l,3,4,5)P^ might also be involved 
in promoting calcium entry. This work showed that a sustained calcium current 
could be only activated when both Ins(l,3,4,5)P^ and Ins(l,4,5)Pj were present 
(Morris et al, 1987). Diacylglycerol (DG) has also been implicated as a second 
messenger which promotes calcium entry, but not in smooth muscle. It has been 
shown to facilitate calcium entry in Aplysia neurones (Deriemer et al, 1985), 
Herissenda photoreceptors (Farley & Auerbach, 1986) and rat adrenal medulla 
(Wakade, Malhotra & Wakade, 1986).
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Calcium Release
(a) Release o f Intracellular Calcium by Second Messengers: The two known 
second messengers in smooth muscle which are produced on receptor activation 
are Ins(l,4,5)P5  and cAMP. Alpha-adrenoreceptor activation has been shown 
to produce Ins(l,4,5)Pj. Its best understood function is to release calcium from 
the sarcoplasmic and endoplasmic reticulum. This was first reported by Streb 
and colleagues (1983) in rat pancreatic acinar cells and subsequently in smooth 
muscle (Suematsu et al, 1984; Somlyo et al, 1985; Hashimoto et al, 1986). None 
of the other compounds produced in the phosphatidylinositol (Ptdlns)
cycle have been shown to release calcium to the same extent as Ins(l,4,5)P3. 
The Ptdlns cycle is discussed in more detail in the introduction to Chapter 5 and 
reviewed by Berridge and Irvine (1984, 1989). There are no reports that cAMP 
influences mobilisation of calcium from the intracellular store. Instead it is 
thought to have its effect by influencing myosin light chain kinase (MLCK) 
(Ruegg & Paul, 1982) decreasing its ability to phosphorylate the myosin light 
chain and hence to interact with actin, thus causing relaxation.
(b) Calcium Induced Calcium Release: It has already been shown in 
skeletal and cardiac muscle that a rise in [Ca2+] in the vicinity of the 
sarcoplasmic reticulum (SR) induces a further regenerative release of calcium 
from the SR (Endo, Tanaka & Ogawa, 1970; Fabiato & Fabiato, 1975; Barsotti 
et al, 1988). However, no direct evidence of a similar nature has been shown 
in smooth muscle. Itoh, Kuriyama and Suzuki (1981) and Obaro, Ito and Yabu
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(1987) have both shown that the calcium content of the SR was reduced when 
the bathing [Ca2+] was increased. Thus calcium induced calcium release might 
have a role in the modulation of the calcium content of the smooth muscle 
sarcoplasmic reticulum. It has yet to be shown, however, that calcium induced 
calcium release is involved in the calcium release mechanism in smooth muscle.
Calcium induced calcium release has been postulated as the mechanism 
by which Ins(l,4,5)P3  causes a uniform calcium release within non-excitable cells 
(Gilkey et al, 1987; Busa et al, 1985; Miyazaki et al, 1986; Lakatta et al, 1989). 
However, it has been dismissed as the mechanism by which Ins(l,4,5)P3  releases 
calcium in smooth muscle by Somlyo et al (1990) because procaine (a known 
blocker of calcium induced calcium release) does not block Ins(l,4,5)P3  induced 
calcium release.
STORES OF INTRACELLULAR CALCIUM
A rise in cytoplasmic [Ca2+] is usually triggered by a surface membrane 
event. For the majority of the work contained in this thesis this has meant 
activation of a membrane bound receptor by its agonist. How this activation is 
propagated from the receptor to the intracellular source of calcium is discussed 
in detail in the introductions of Chapters 4 and 5. Briefly the agonist binds to 
its receptor which activates a G-protein in membrane. The G-protein in turn 
activates the enzyme phospholipase C which splits phosphatidylinositol 
(4,5)bisphosphate to produce inositol(l,4,5)triphosphate and diacylglycerol. 
Both of these compounds then have effects on calcium release from the SR,
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entry across the sarcolemma and calcium sensitivity of the contractile proteins. 
The intracellular sites for calcium storage previously thought to be involved 
include: (a) sarcoplasmic reticulum; (b) mitochondria; and (c) surface
membrane.
(a) Sarcoplasmic reticulum'. It has now been universally accepted that the 
source of intracellular calcium is the sarcoplasmic reticulum (SR). This has not 
always been the case even although there is an obvious parallel with skeletal and 
cardiac muscle (Endo, 1977). This was mainly due to an early work by Peachy 
and Porter (1959) who reported that smooth muscle had a scarcity of SR. This 
finding was backed by Somlyo and Somlyo (1968) and prompted the search for 
an alternate source of calcium. Peachy and Porter’s findings were later 
discovered to be in error. The primary fixative that they had used partially 
destroyed the smooth muscle and in addition they had been unfortunate in 
choosing types of smooth muscle that had a small amount of SR (Devine, 
Somlyo & Somlyo, 1972; Gabella, 1981). In fact, an SR that occupies no more 
that 2 % of the cell volume can store enough calcium to activate maximal 
contraction (Bond et al, 1984a; Kowarski et al, 1985).
The SR is an intracellular membrane system of tubules (Somlyo et al, 
1971). These tubules exclude extracellular markers such as ferritin, horseradish 
peroxidase or collodial lanthanum. The Na and Cl concentration in the SR, 
measured with electron probe analysis (Kowarski et al, 1985) is similar to the 
cytoplasmic but not the extracellular concentrations, indicating that the SR is not 
in direct ionic communication with the extracellular space. The SR can occupy
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about 1.5 to 7.5% of the total cell volume depending on the smooth muscle 
type, being most extensive in the large elastic arteries (e.g. rabbit aorta and 
main pulmonary artery) and in pregnant uterus (Somlyo & Somlyo, 1975; 
Garfield & Somlyo, 1985). The longer persistence of contractions in nominally 
calcium-free solutions in large elastic arteries, compared to taenia coli and portal 
vein, was originally related to the smaller volume of SR in the latter types of 
(phasic) smooth muscle. However, it has since been demonstrated that guinea 
pig portal vein smooth muscle, which contains only 2% SR can contract 
maximally in nominally calcium-free solutions (Bond et al, 1984a).
The SR’s ability to accumulate calcium has been demonstrated using 
strontium. Calcium and strontium are taken up by the SR using the same 
transport mechanism. Strontium is more electron-dense than calcium which 
allows it to be visualised using an electron microscope. Strontium was 
accumulated in both quiescent and activated cells (Somlyo & Somlyo, 1971). 
Electron probe analysis was used to demonstrate that calcium was accumulated 
by smooth muscle SR (Somlyo et al, 1979; Popescu & Diculescu, 1975; 
Heumann, 1976; Somlyo et al, 1982). Physiological experiments demonstrating 
the ATP-dependence of such calcium uptake also identified the SR as the 
calcium store (Endo et al, 1982). The calcium content was measured with 
electron probe micro analysis in relaxed vascular smooth muscle (Bond et al, 
1984a; Kowarski et al, 1985). It was estimated to be 28mmol/kg dry weight in 
the junctional SR of the guinea pig portal vein and 15-18mmol/kg dry weight in 
the central SR of the rabbit main pulmonary artery. These concentration are
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considerably higher than those found in the cytoplasm and provide further 
evidence for the accumulation of calcium by the SR.
It has been known for a considerable time that smooth muscle can contract 
in the virtual absence of extracellular calcium and this was taken as evidence for 
the release of calcium from intracellular stores (Devine et al, 1972). The fact 
that this calcium was stored in the SR was harder to prove. Changes in the 
calcium content of the SR could be examined using electron probe micro 
analysis (Bond et al, 1984a; Kowarski et al, 1985). These latter two groups 
examined two different vascular smooth muscle preparation. One was 
spontaneously active and highly excitable muscle, guinea pig portal vein, and the 
other a quiescent and poorly excitable muscle, main pulmonary artery. It was 
discovered that these two muscle preparations had different amounts of SR, 2 
and 7.5% of total cell volume respectively, but that each could release enough 
calcium to cause a maximal contraction. However, they both released their 
calcium from different SR sites within the muscle. Guinea pig portal vein 
released it from the junctional SR and main pulmonary artery released it from 
the central SR.
(b) Mitochondria: Mitochondria have a relatively low affinity, but very 
large capacity for accumulating calcium. The apparent Km of mitochondria 
isolated from smooth muscle for calcium is only 10-17/xM (Vallieres, Scarpa & 
Somlyo, 1975; Wikstrom, Ahonen & Luukkaine, 1975). In smooth muscles that 
are not damaged or experimentally exposed to unphysiological high free 
cytoplasmic [Ca2+], the mitochondrial [Ca2+] ranges from 0 to 3 mmol/Kg dry
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weight (Somlyo, Somlyo & Shuman, 1979; Bond et al, 1985) This [Ca2+] is 
comparable with the estimate made for cardiac mitochondria (Denton & 
McCormack, 1980; Hansford & Castro, 1982). These latter workers also 
suggested that this range of free intra-mitochondrial [Ca2+] would regulate 
certain important mitochondrial enzymes (e.g. dehydrogenase). The Somlyo’s 
claim that mitochondria do not have any role in calcium accumulation has been 
disputed (Miller, 1985). This author suggests that relaxation can be induced in 
smooth muscle if the mitochondiria sequesters ImM [Ca2+] which is a 
concentration taht is below the detection level of X-ray probe microanalysis and 
that mitochondria might only be transiently accumulating calcium before 
transferring it to the SR.
(c) Surface Membrane: The bidirectional transport of calcium across the 
plasma membrane and the role of membrane-bound calcium itself are the two 
major functional aspects of the participation of the surface membrane in cellular 
calcium metabolism. There is much evidence based on measurement of 
radioactive calcium isotope flux (Jones, 1980; Fleckenstein, 1983), 
electrophysiological (Somlyo & Somlyo, 1971) and electron probe microanalytical 
(Bond et al, 1984a) studies showing that excitation by potassium depolarisation 
or noradrenaline can increase calcium influx across the surface membrane. If 
this is a maintained influx, calcium accumulates in the SR (Somlyo & Somlyo, 
1971, 1975; Bond et al, 1984b; Somlyo et al, 1985) and binds to calcium- 
cytoplasmic binding proteins (Bond et al, 1984b). The amount of calcium bound 
to the surface membrane is lower than that contained in the lumen of the SR
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(Bond et al, 1984b) and it is unknown whether calcium from this site can be 
released into the cytoplasm.
MECHANISM OF FORCE PRODUCTION IN SMOOTH MUSCLE
Smooth muscle cells are spindle-shaped, about 5-50/un wide and up to 
0.5mm long. They contain double the concentration of actin and tropomyosin 
as skeletal muscle, but a four to five times lower concentration of myosin 
(Murphy, Heruhy & Megerman, 1974). This difference has a structural 
correlate. Within smooth muscle cells, actin and myosin filaments are organised 
in bundles in such a way that each myosin filament is surrounded by up to 1 0  
or 15 actin filaments. The latter may be several long and 8 nm thick (Small, 
1974). Myofilament bundles are obliquely orientated within the spindle-shaped 
smooth muscle cells as they run diagonally from an attachment point on the cell 
membrane through the cell and insert at an attachment point on the opposite 
side of the cell. Quite often, the position of the attachment patches of 
neighbouring cells match. Since the narrow gap between these patches is 
bridged by electron dense material, the cells are evidently mechanically coupled. 
In this way, smooth muscle cells form a contractile network to which collagen 
fibres may be attached (Gabella, 1984).
At the molecular level, the mechanism of contraction in all muscles is 
believed to be the same (Marston & Taylor, 1980). Crossbridges arising from 
the myosin filaments bind actin and MgATP, the MgATP is hydrolysed on the 
enzymic site and the energy released is used to produce a conformational
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change in the actin-myosin complex which results in a relative movement of the 
two filaments (Tregear & Marston, 1979).
For smooth muscle, as for skeletal muscle, it is generally accepted that it 
is calcium ions which link excitation with contraction. The first demonstration 
of calcium regulation in smooth muscle was given by Filo, Bohr and Ruegg 
(1965). They found that glycerol extracted muscle from pig carotid artery 
required Mg2-1", ATP and Ca2+ for contraction. Tension production was 
absolutely dependent on Ca2+.
A calcium-dependent MgATPase was subsequently demonstrated in smooth 
muscle homogenates from various sources (Murphy et al, 1969; reviewed by 
Marston, 1982) but attempts at isolating the contractile proteins usually 
produced preparations with low MgATPase activity and no calcium sensitivity 
(Needham & Williams, 1963; Barany et al, 1966; Murphy et al, 1969). The first 
successful smooth muscle actomyosin preparation was developed by Sparrow et 
al (1970) using pig carotid artery. Once a satisfactory method for isolating 
actomyosin had been developed Bremel (1974) was able to show that, unlike 
striated muscle, the myosin activity of chicken gizzard smooth muscle was 
regulated by calcium. These experiments failed to show any calcium regulation 
by the actin filaments and isolated actin filaments exhibited no calcium-binding 
(Sobieszek & Small, 1976; Sobieszek, 197^). Consequently attention became 
focused on myosin linked calcium regulation. At first it was thought that 
calcium activated smooth muscle myosin by binding to it directly (Sobieszek & 
Small, 1976). However, because it was already known that purified smooth
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muscle myosin had a reduced actin activated MgATPase activity (Barany et al,
1966; Yamaguchi, Miyazawa & Sekine, 1970, Driska & Hartshorne, 1975) it
became apparent that components in addition to actin were required for
activation of the myosin-MgATPase activity in smooth muscle. It seemed
unlikely, therefore, that calcium would be having its effect on myosin directly.
In 1977 Sobieszek observed that there was a calcium-dependent
phosphorylation of the 20,000 Mol.wt. light chain component of myosin in
chicken gizzard actomyosin preparations. The calcium dependence of
phosphorylation was close to that of the activation of myosin-MgATPase activity
and both high ATPase activity and phosphorylation persisted after the removal
of calcium. These observations were quickly confirmed in most smooth muscle
a.
types; gizzard (Sobieszek, 1977; Aksoy et al, 1976), blood vessels (di Salvo,
Gruenstein & Silver, 1978), uterus (Lebowitz & Cooke, 1979), vas deferens
(Chacko, Contim & Adeldstein, 1977) and stomach (Small & Sobieszek, 1977a).
Further studies in several laboratories led to the phosphorylation model of
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smooth muscle regulation (Sobieszek, 1977; Small & Sobieszek, 1977; Adelstein 
et al 1977; Adelstein, 1978; Hartshorne et al, 1977). This model states that 
actin cannot activate myosin MgATPase activity unless the 20,000 Mol.wt. myosin 
light chain is phosphorylated. Phosphorylation is catalyzed by a specific myosin 
light chain kinase (MLCK) which is activated by calcium at concentrations 
similar to those required to activate striated muscle actomyosin MgATPase. 
Dephosphorylation of myosin and hence inhibition of actomyosin MgATPase 
activity, is catalyzed by a specific phosphatase which is active irrespective of the
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[Ca2+]. Subsequent purification of phosphorylated and unphosphorylated 
myosin, the myosin light chain kinase and the phosphatase has supported this 
model, although it has not excluded the possibility of direct calcium regulation 
of myosin also occurring under some conditions (Chacko et al, 1977).
When the MLCK was further purified, in an effort to discover how it was 
controlled by calcium, it lost its activity. Dabrowska and colleagues (1977) 
showed that the kinase could be reactivated by the calcium-dependent regulator 
of cyclic nucleotide diesterase, discovered by Cheung (1970) and later termed 
’calmodulin’. Calmodulin is a highly coiled globular molecule with a Mol.wt. 
of 17,000, containing 148 amino acid residues organized in four calcium binding 
domains (Babu et al, 1985). Under physiological conditions, calmodulin is 
capable of binding Ca2+ in the physiologically important concentration range of 
0.1/xM to 10/xM. When occupied with four calcium ion, calmodulin changes its 
shape such that the hydrophobic sites from the interior of the molecule become 
exposed to the outside. This increases the affinity of calmodulin for target 
proteins including MLCK (Adelstein et al, 1981).
Since calmodulin’s affinity for myosin light-chain kinase is 
calcium-dependent, it can act both as a calcium sensor and a calcium switch for 
the regulation of the enzymic phosphorylation of smooth muscle myosin; it is 
the ternary complex of calcium-calmodulin-MLCK that represents the active 
enzymic moiety. The concentration of this complex, therefore, depends on both 
the concentration of free calcium and free calmodulin. It has been estimated 
that smooth muscle contains 30-50/xM calmodulin although most of this is bound
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to calmodulin binding proteins (Grand & Perry, 1979) so that only a very small 
fraction of calmodulin is available and responsible for smooth muscle activation 
(Ruegg et <2 /, 1984).
The phosphorylation hypothesis for smooth muscle contraction and 
relaxation is shown diagramatically in Figure 1.1 (taken from Ruegg, 1988). 
When the [Ca2+] rises sufficiently calmodulin binds four calcium ions and can 
then react with myosin light chain kinase to a form an active ternary enzyme 
complex. This complex catalyzes the phosphorylation of myosin. Actin can then 
interact with the phosphorylated myosin which increases its ATPase activity and 
the muscle ’contracts’.
Lowering the [Ca2+] to an appropriate level depresses the myosin light 
chain kinase activity. The myosin then tends to be dephosphorylated by a 
myosin phosphatase (Di Salvo et al, 1983) resulting in an inhibition of 
actomyosin ATPase. This causes muscle to relax. The activity of the 
phosphatase is independent of the [Ca2+]. Thus during contraction it is a 
balance of kinase and phosphatase activity which controls the level of 
phosphorylation and hence the extent of activation of the muscle.
Dephosphorylated myosin has a low ATPase activity and is less able to 
interact with actin. Under these conditions, the rate limiting step of the 
ATP-splitting mechanism, presumably the dissociation of the actomyosin-ADP 
state, appears to be inhibited (Marston, 1982; Sellers, 1985). It is possible, 
therefore, that the dephosphorylated light chain is an inhibitor of actin-myosin
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Figure 1.1 Myosin phosphorylation regulates smooth muscle contraction. 
Activation is initiated by Ca2+, myosin light chain kinase and calmodulin forming 
the active ternary comlex which catalyzes the phosphorylation of the myosin light 
chain kinase. When Ca2+ is lowered the calmodulin-myosin light chain kinase
complex decomposes and myosin is dephophoiylated by myosin light chain
!
phosphatases. Only phophorylated myosin interacts with actin to form ’cycling’, 
ATP-hydrolysing contractile crosslinkages.
22
interaction in smooth muscle. Indeed, myosin subfragment S-l is fully 
en2ymically active in the presence of actin when the regulatory light chain has 
been removed (Mrwa & Ruegg, 1977).
Although the phosphorylation hypothesis is the most widely accepted 
explanation of how smooth muscle contracts, there are other theories. There 
are at least three other different mechanisms which have been proposed to 
account for smooth muscle activation in the absence of additional 
phosphorylation of myosin: ( 1 ) calcium binding to myosin; (2 ) activation by
leiotonin; and (3) regulation by the thin-filament proteins caldesmon and 
tropomyosin.
(1) Calcium Binding to Myosin: Chacko and Rosenfeld (1982) showed that 
actin binding to myosin could be increased once it had been phosphorylated by 
increasing the [Ca2+] in the bathing medium. These workers suggested that 
calcium was having this effect by binding to the myosin light chains.
(2) Activation by Leiotonin: Ebashi (1980) described the properties of 
leiotonin, a calcium-dependent activator of smooth muscle contraction; it binds 
calcium, requires tropomyosin as a cofactor and increases actomyosin-ATPase 
activity without any increase in myosin phosphorylation.
(3) Regulation by the Thin-filament proteins Caldesmon and Tropomyosin: 
Marston and Smith (1984) isolated, from vascular smooth muscle, a preparation 
of actin filaments that activated myosin ATPase in a calcium-dependent manner. 
These results suggested that the thin filament muscle proteins include regulatory
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proteins conferring calcium sensitivity on the contractile system. It was 
suggested that these proteins were (i) caldesmon and (ii) tropomyosin.
(i) Caldesmon can bind both actin and calmodulin and it has been 
postulated to be the calcium regulatory component of the thin filament (Marston 
& Lehman, 1985). In the absence of calcium ions, caldesmon binds actin rather 
than calmodulin and possibly prevents the protein from interacting with myosin. 
In the presence of calcium, it tends to bind to calmodulin rather than actin 
relieving its possible inhibitory action (Sobue et al, 1982). There are reports 
that caldesmon has to be phosphorylated by a calcium/calmodulin-dependent 
protein kinase before it is able to bind calmodulin (Nagai & Walsh, 1984, 1985).
(ii) Tropomyosin has been reported (Merkel, Meisheri & Pfitzer, 1984) 
to increase the calcium sensitivity of a hybrid actomyosin made up of skeletal 
muscle actin and supplemented with myosin light chain kinase and calmodulin. 
At an intermediate [Ca2+], total muscle myosin is partly phosphorylated and its 
ATPase partly activated, whereas at the same calcium concentration addition of 
tropomyosin increases myosin-ATPase activity without increasing the extent of 
phosphorylation. It appears, therefore, that tropomyosin improves 
phosphorylation-contraction coupling and this allows the contractile system to 
operate at a lesser degree of myosin phosphorylation.
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AIMS
The introduction has discussed the factors involved in smooth muscle 
contraction. The aim of this thesis was to obtain a better understanding of the 
inolvement of G-proteins and the phosphatidylinositol cycle in receptor activation 
in rat anococcygeus. Their involvement was examined in both intact and 
permeabilized muscle. Special interest was paid to their role in modulating 
calcium release from the sarcoplasmic reticulum and caclium-activated force.
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CHAPTER 2 
MATERIALS AND METHODS
A. INTACT MUSCLE
PREPARATION
Male rats (250 - 300g) were killed by a blow to the back of the head 
followed by exsanguination. The two ’legs’ of the anococcygeus muscle were 
rapidly removed and placed in a petri dish filled with warm Krebs solution 
(composition shown in Table 2.1, column 1).
POSITION
The two ’legs’ of the anococcygeus muscle arise from the coccygeal 
vertebrae close to one another in the midline of the pelvic cavity. The muscles 
pass caudally, lying first behind and then to one side of the colon, finally joining 
together to from a ventral bar in front of the colon a few millimetres from the 
anus
HARVESTING
The abdomen was opened at the midline. The testes, bladder and seminal 
vesicles were removed. Two incisions were then made from the abdomen into 
the scrotum, the penis was cut at its base and the skin pulled back. The pelvis 
was split and the colon cut and carefully pulled back to reveal the anococcygeus 
muscle. Any connective tissue around the muscle was carefully removed, the 
tissue was tied with cotton thread just above where the muscle inserts into the 
coccygeal vertebrae and at the point where it meets with the colon. Hence the
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TABLE 2.1.
Krebs Low Calcium Krebs Tvrode 
Compound (mM) (mM) (mM)
NaCl 118.4 118.4 150
KC1 4.7 4.7 5
MgS04  1 . 2  1.2
MgCl2  - - 2
CaCl2  1.25 0.25 1.25
NaHC03  15 15
Hepes 25
KH2 P 0 4  1 1 1
EDTA 0.0023 - 0.0023
EGTA - 0.5
Cocaine 0.003 0.003 0.003
Glucose 1 1 . 1  1 1 . 1  10
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of muscle used in these experiments did not include the ’bar’ of tissue around 
the colon, but only the ’legs’ of the muscle, as shown in Figure 2.1.
EQUIPMENT
Once the muscle had been removed from the animal, it was suspended in 
a 10ml organ bath as shown in Figure 2.2. The muscle was attached at one end 
to a fixed point in the bath by cotton thread. The other end was also attached, 
by cotton thread, to an isometric force transducer (Harvard, Grass FT03). The 
solution in the organ bath was aerated with 95% 0 2  and 5% C 0 2  and was kept 
at 37°C by circulating water from a heated water bath. The pH buffer used in 
these experiments was usually bicarbonate and the pH was approximately 7.4. 
The signal from the transducers was amplified and displayed on a Grass 
Polygraph.
SETTING UP
Once the muscle had been attached to the transducer and the fixed point 
as described previously a resting tension of IN was applied. The muscle was 
allowed to relax and resting tension was restored twice over a 15 minute period. 
The bathing medium was replaced before each new application of tension. The 
muscle was then allowed to relax for a further 30 minutes. At the end of this 
period, the bathing medium was replaced and a ’priming dose’ of noradrenaline 
(30/iM) was added to the bath. The muscle was allowed to contract for 5 
minutes and then the bathing medium was replaced every 5 minutes for 15
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Figure 2.1 Position of the anococcygeus muscle in the male rat. The muscle 
lies deep to the colon in the pelvic cavity, originating from a tendinous contact 
with the coccygeal vertebrae and running around either side of the colon to join 
together on its ventral surface just short of the anal margin. This diagram has 
been taken from Prof. J.C. McGrath’s PhD thesis.
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Perspex Tissue Holder
Transducer
Cotton Thread
Heated Glass Organ Bath
Heated Water Entry
Muscle
Heated Water Exit
Gassing Scinter
Gas (5% CQ/95% 0 2)
Figure 2.2 The experimental set-up used in the intact muscle experiments. The 
diagram is a representation of an organ bath and shows how the muscle is 
attached to the transducer and positioned in the organ bath.
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minutes. The muscle was then allowed to relax for a further 30 minutes or until 
the resting tension had returned to control levels. The muscle was now ready 
for experimentation. This same protocol was used to prepare muscles which 
were subsequently bathed in low calcium Krebs (0.1/zM) to examine intracellular 
release of calcium. The composition of this bathing medium is shown in Table 
2 .1 , column 2 .
SOLUTIONS
The solutions used are detailed in Table 2.1. These solutions were made 
up fresh each day.
DRUGS
The drugs used are listed in Table 2.2.
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TABLE 2.2.
COMPOUND SUPPLIER
ATP (disodium salt) Sigma Chemicals, Poole, Dorset, England
CrP (disodium salt) "
EDTA
EGTA
cAMP
GTP
GTP-y-S
GDP-6 -S
Hepes "
Saponin "
Caffeine "
Myoinositol "
Methansulphonic acid "
Propionic acid "
KH2 P04.2H20
Noradrenaline "
Acetylcholine "
5-Hydroxytryptamine "
Phenylephrine "
KC1 BDH Chemicals, Poole, England
NaCl " V  "
LiCl
KOH (1M titration standard) "
NaOH (1M titration standard) "
CaCl2  (1M titration standard)
MgCl2  (1M titration standard) "
Atropine sulphate 
Glucose 
Sucrose 
IP3
UK14304 
Prazosin 
Nifedipine 
Crude alpha-toxin
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Formachem, Strathaven, Scotland
i t
Calbiochem, California, USA 
Gift - Pftizter, Sandwich, Kent
t t
Gift - Bayer, West Germany 
Dept of Cell Biology, Glasgow University
B. PERMEABILIZED MUSCLE
PREPARATIONS
Adult male Wistar rats (250 - 270g) and adult female Dunkin Hartley 
guinea pigs (300 - 350g) were killed by a blow to the back of the head followed 
by exsanguination. Rat anococcygeus was removed as described previously. 
Guinea pig portal vein was found by opening the abdomen along the midline 
and displacing the intestines to one side revealing the vein. A piece of tissue 
of about 1 cm in length was removed below the bifurcation where the vein enters 
the liver. This was placed in a beaker of Tyrode solution (composition shown 
in Table 2.1, column 3) and then transferred to the dissecting dish. Any 
connective tissue and fat were carefully removed under the microscope using 
fine scissors and the adventitia was removed. Once it was clean the vein was 
opened along its length and pinned out. The anococcygeus muscle was cleaned 
up in a similar manner after its removal. Small strips (100/mi wide by 2-3mm 
long) of anococcygeus and of the longitudinal muscle of the portal vein were cut 
using fine scissors.
SETTING UP
The muscle was then mounted between a fixed point and a transducer. 
The fixed point, as shown in Figure 2.3, comprises a brass rod which has three 
pieces of hollow stainless steel tubing with an outside diameter of 2 0 0 /xm and 
an inside diameter of 100/mi (Goodfellows) glued to it (Super glue, Loctite).
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Transducer Pin Monofilament
Fixed Point
Stainless Steel Hollow Tubing
Snared Muscle
Figure 2.3 diagram (components not to scale) of the experimental arrangement 
used to measure tension in permeabilized muscle. The muscle is snared 
between the transducer and a fixed point.
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The piece of tubing extending farthest has been threaded (nylon monofilament) 
such that a loop of thread extends from the bottom to form a snare. A similar 
arrangement exists on the transducer. The transducer and fixed point are 
mounted on a magnetic block and Narashige MM3 micromanipulator. This 
allows them to be moved relative to each other as well as together in 3 planes. 
The muscle is mounted under a dissecting microscope by passing it through 
both snares which are tightened when the muscle is in place to hold it securely. 
The mounted preparation is then transferred to the bath system. Once in the 
bath system the muscle has a resting tension of 0.5mN (rat anococcygeus) or 
O.lmN (guinea pig portal vein) applied. The muscle is allowed to relax for 30 
minutes before the experiment begins.
EQUIPMENT
The bath system comprises of a series of wells which have been cut out 
of a perspex block. Each well holds either 0.95 or 4.65mls of solution. The 
bath system fits into a perspex holder which can be moved in two planes by a 
horizontal and vertical stepper motors. These motors are controlled by an 
Apple II microcomputer. To change solutions the bath system is lowered moved 
along and then raised again under the preparation. This system and 
accompanying software allow large numbers of accurately timed solution changes 
to be preprogrammed. Solutions were continuously stirred by a stainless steel 
paddle
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TENSION MEASUREMENT
The output of the tension transducer was amplified, filtered at 25Hz and 
displayed on a chart recorder (Linseis 1800). It was also simultaneously 
digitised. The signal was recorded on videotape via an A/D VCR adaptor 
(PCM 4/8, Medical systems corp. Greenvale, N.Y.) and video recorder. The 
data were then transferred from the videotape to an IBM computer (via a data 
translation board) for further analysis.
SOLUTIONS
The solutions used daily were made from stock solutions. The stocks were 
made at regular intervals and stored in the ’fridge’. These were 1M KC1 and 
MgCl2, lOOmM CaEGTA, EGTA and KH2 PO„ and 500mM Hepes. The 
amount of EGTA added to the stock solution was calculated with reference to 
recent reports regarding the purity of EGTA obtained from Sigma (Bers, 1982, 
Miller & Smith, 1984) The appropriate concentrations (Table 2.3) of these 
stock solutions were mixed together and the appropriate amounts (Table 2.3) 
of Na2ATP, Na2CrP and glucose were added. When KCHjSOj was used it was 
either made up fresh from methansulphonic acid and potassium hydroxide or 
prepared then stored in the freezer and defrosted on the day of use.
There are three basic solutions ’10 activating’ (which contains lOmM CaEGTA), 
’10 relaxing’ (which contains lOmM EGTA) and ’0.2 relaxing’ (which contains 
0.2mM EGTA). The full composition of these solutions are shown in Table 2.3. 
The strongly calcium-buffered solutions -’10 activating’ and ’10 relaxing’ - are
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TABLE 2.3.
SOLUTION 10 ACTIVATING 10 RELAXING 0.2RELAXING
(mM) (mM) (mM)
KC1 or KCH3 SO3  120 120 120
Hepes 25 25 25
Na2 CrP 15 15 15
EGTA - 10 0.2
CaEGTA 10 - -
MgCl2  7.0 7.0 7.0
Na2ATP 5.0 5.0 5.0
(pH 7.0 - adjusted with KOH, Ionic strength 0.2M)
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used to examine calcium-sensitivity. To obtain the appropriate free [Ca2+] in 
the bath, these solutions were mixed together. The free [Ca2+] was calculated 
using a computer programme (REACT) written by G. L. Smith and D. J. Miller. 
The affinities of EGTA and the other ligands for calcium and the other metal 
ions have been incorporated. REACT can provide a complete profile of the 
free metal ion concentrations and ligand-mental concentrations. For details of 
the binding constants and correction for pH, ionic strength and temperature 
which were employed, see Smith and Miller, (1985). The weakly calcium 
buffered solution (’0 . 2  relaxing’) was used to examine calcium release from the 
sarcoplasmic reticulum. The [Ca2+] of the ’0.2 relaxing’ solution was increased 
to allow store loading by addition of CaCl2. As the EGTA in the ’0.2 relaxing’ 
solution is not saturated, addition of calcium results in the net release of 
approximately 2 hydrogen ions per calcium-bound at pH 7.0 (Smith & Miller, 
1985). Consequently, the appropriate amount of KOH was added to maintain 
the solution at pH 7.0. All the chemicals and drugs used are listed in Table 2.2.
pH
This is a very important factor since it is in the nature of the 
experimentation that the solutions directly bathe the contractile proteins and 
intracellular organelles. These organelles naturally work at a constant pH of 7.0 
and are affected by changes in pH. Furthermore, the apparent binding 
constants of EGTA and ATP for Ca2+ and Mg2-1" are highly pH sensitive. The 
pH buffer Hepes (25mM) was used to minimise pH changes during contracture.
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The useful buffering range of Hepes is pH 6.5-7.5.
The pH of the experimental solutions was adjusted using a null point 
method. A standard solution was prepared, which was calculated to have the 
same pH (activity) and ionic strength (0.2M) as the solutions. The electrodes 
were allowed to equilibrate in the pH-standard and then all other solutions were 
adjusted to the pH by the addition of KOH. The pH electrodes used in this 
study consisted of separate reference (Corning 003116029) and pH electrodes 
(Corning 0031101J). For details of the composition of the pH standard solution 
see Harrison et al, (1988).
IONIC STRENGTH
Ionic strength (I) in this study has been calculated using the equation: 
le = 1/2 Cj.Zj. Ionic strength is defined as the total of the ionic equivalents (Ie) 
where C; is the concentration of the jth ionic species and z;- is its valency. Ionic 
strength for the large majority of this study has been set at 0.2M. It was 
adjusted by changing the concentration of KC1 in the solutions.
PERMEABILIZATION TECHNIQUES
These are discussed in detail in the Materials and Methods section of 
Chapter 3.
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CHAPTER 3
A COMPARISON OF THREE DIFFERENT METHODS 
USED TO PERMEABILIZE SMOOTH MUSCLE
INTRODUCTION
The ’skinned’ muscle preparation has been in existence for over 35 years. 
A ’skinned’ muscle is one in which the surface membrane has been removed or 
permeabilized to such an extent that there is free diffusion of small ions and 
other solutes between the extracellular and intracellular media. Hence by 
changing the extracellular medium, the intracellular medium and therefore the 
environment surrounding the contractile proteins and intracellular organelles can 
be controlled. Over the 35 years a number of skinning methods have been 
developed. These have had varying degrees of success in the different muscle 
types. The majority of the techniques were developed for skeletal muscle and 
have subsequently been used on cardiac and most recently, smooth muscle. The 
different methods will be discussed in this chapter.
Szent-Gyorgyi (1949) was the first to describe and use a method of 
preparing glycerinated skeletal muscle fibres. This method, which retains the 
native structure of the myofilaments, has been applied to visceral and vascular 
smooth muscle (Briggs, 1963; Filo, Bohr & Ruegg, 1965; Bozler, 1968). In these 
studies the time course of tension development induced by the removal of ATP 
and by the increase of free [Ca2+] was extremely slow in comparison with that 
of the living state. It was thought that the long exposure to glycerol (up to 3 
months in some instances) was damaging the internal organisation of the muscle 
such that it could no longer respond in the same manner as the intact muscle.
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Natori (1954) introduced a new technique which involved the mechanical 
removal of the surface membrane of skeletal muscle fibres. The technique had 
an advantage over the glycerinated fibres in that the intracellular organelles were 
left intact. This, however, is technically a very difficult method for skinning, 
especially in smaller muscle cells, such as cardiac and smooth muscle cells. It 
has, however, been successfully adapted by Fabiato and Fabiato (1973) for use 
in single cardiac muscle cells, but has not yet been applied to smooth muscle 
cells.
Another method of permeabilizing muscle was introduced in 1971 by 
Winegrad. This method involved exposing the muscle, in this instance frog 
ventricular muscle, to a solution which contained 3mM EDTA for 15 mins. 
The muscle was thereafter:
(1) responsive to raising the [Ca2+];
(2) had a membrane potential between +10 and +15 mV; and
(3) could no longer initiate an action potential.
These effects could be reversed by raising the [Ca2+]. Winegrad postulated 
that the muscle was made permeable by the low [Ca2+] and [Mg2+] present in 
the EDTA solution. This technique was also used by two groups (Mrwa, 
Archtig, & Ruegg, 1974; Baguet & Marchand-Dumont, 1975) to permeabilize 
smooth muscle. Both these groups found that, following this treatment, the 
muscle was as sensitive to calcium as a muscle treated with glycerol. However, 
they both reported that the muscle showed slower rates of contraction and 
relaxation than the intact muscle. Baguet and Marchant-Dumont (1975)
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reported that the anterior byssus retractor muscle (ABRM) took twice as long 
to contract as a glycerol-treated muscle and six times longer to relax. This 
group also reported that the muscle responded in a similar manner whether it 
is EDTA- or Triton-treated. However, the exposure to Triton X-100 (see later) 
lasted only 1 0 -2 0 s and might have been inadequate to ensure that the 
preparation had been permeabilized through its entire radius. In an effort to 
reduce the reversibility of the EDTA technique and to achieve a more profound 
permeabilization, McClellan and Winegrad (1978) used EGTA (3mM) to reduce 
the [Ca2+] and incubated rat cardiac muscle for 12-18 hours at 0-4°C. Rat 
cardiac muscle treated in this manner was still responsive to calcium. However, 
this responsiveness was increased further after the muscle was treated with the 
non-ionic detergent Triton X-100. McClellan and Winegrad (1978) explained 
this discrepancy as a result of the removal of membrane bound enzymes by 
Triton X-100 and indeed when the phosphodiesterase inhibitor theophylline was 
added the calcium sensitivity of the muscle was similar to that of the Triton 
X-100 permeabilized preparation. However, the effect that theophylline would 
be having directly on the contractile proteins was not explored.
There is much evidence for the ineffectiveness of the EGTA-skinning 
technique for cardiac (Miller, 1979; Kentish & Jewell, 1984; Miller, Elder & 
Smith, 1985; Miller & Smith, 1985) and smooth muscle (Cornelius 1980). Using 
ultrastructural and microanalytical techniques, Miller et al (1985) showed in rat 
trabeculae that La and LaEGTA could gain entry to muscles which had been 
permeabilized with Triton X-100 and Saponin but not EGTA permeabilized
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muscle. Kentish and Jewell (1984) and Miller and Smith (1985) reported that 
EGTA-treated and Triton X-100-treated preparations had different response 
times to calcium and responded very differently when ATP and CrP were 
removed. Both sets of authors reported that EGTA-treated preparations had 
a lower apparent diffusion coefficient for calcium than Triton X-100-treated 
preparations. In addition, Miller and Smith (1985) reported that 
EGTA-treatment was not dependent on a low extracellular [Ca2+]. That is, the 
muscle performed in the same manner regardless of whether the disruption 
solution had a low [Ca2+] or not. There is evidence that it is ATP which causes 
the permeabilization (Gomperts, 1983). Tatham and Lindau (1990) have shown 
that it is the ATP'*' form of ATP which causes the formation of the pores in 
mast cells. After exposure to ATP'*' at a concentration as low as 4jiM ethidium 
bromide and l-(4-trimethylammoniumphenyl)-6-phenyl-l,3,5-hexatriene can gain 
access to the intracellular medium.
Another chemical skinning technique which has been developed involves 
the use of agents that insert into the membrane and disrupt the structure. The 
two main methods used are: (1) the non-ionic detergent Triton X-100 and (2) 
Saponins. Triton X-100 dissolves all membranes including the internal 
membranes (mitochondria and sarcoplasmic reticulum). This essentially leaves 
only the contractile proteins and collagen-elastic networks. Triton X-100 was 
first used to skin smooth muscle by Gordon (1978). It has since been used to 
permeabilize many types of smooth muscle quite successfully. An advantage of
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this technique is that the tension produced by the muscle is equal to that by the 
intact muscle which is not the case in glycerol or EDTA-treated muscle.
Saponins are alkaloids some of which are extracted from plants. The 
saponin available commercially (Sigma and BDH) is derived from the sea 
cucumber Actinopyga agassiza, another which is widely used is derived from the 
alpha-pha plant. Ohtsuki et al (1978) reported that saponin was able to form 
pores in red blood cell ghosts. Saponin acts on cholesterol and, at certain 
concentrations, will selectively remove the cholesterol in the sarcolemma and not 
affect the intracellular membranes. This is believed to be due to the fact that 
these internal membranes contain less cholesterol than the sarcolemma 
(Martonosi, 1968; Waku, Uda & Nakazawa, 1971). This method was applied 
to smooth muscle almost simultaneously by Endo et al (1977) and Saida and 
Nonomura (1978). Both these groups of workers showed that the maximum 
calcium-activated force produced was equal to the maximum tension produced 
by a potassium contracture in the intact muscle. Endo et al (1977) also showed 
that caffeine could release calcium from the intracellular store indicating that the 
treatment had left the sarcoplasmic reticulum intact and functional. Although 
the internal stores of calcium are left intact after this method of permeabilizing 
they cannot be stimulated by activating the surface membrane bound receptors 
(Itoh, Kuriyama & Suzuki, 1983).
These two methods of permeabilizing (Triton X-100 and saponin) have 
particular problems when used in smooth muscle which do not apply to skeletal 
and cardiac muscle. Many workers in the field have reported that
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calcium-activated force in permeabilized muscle deteriorates with time (Endo et 
a l , 1977; Saida & Nonomura, 1978; Gordon, 1978; Ruegg & Paul, 1982; Itoh, 
Kanmura & Kuriyama, 1986). Ruegg and Paul (1982) reported results obtained 
with Triton X-100-treated porcine carotid artery. The inclusion of 4/xM 
calmodulin prevented the decline in calcium-activated force. Itoh et al (1986) 
presented similar data from saponin permeabilized mesenteric artery. 
Contractions induced by repetitive application of 10/jM [Ca2+], declined to 
78% of the first contraction by the third. This was accompanied by a depression 
in calcium sensitivity. This decline could be prevented by including 0.1/iM 
calmodulin in the mock intracellular bathing medium. Kossman, Furst and Small 
(1987) after using biochemical and immunohistochemical analysis of both saponin 
and Triton X-100 permeabilized taenia coli found changes in the protein content 
of the muscle and the distribution of the protein within the muscle. Around 
50% of myosin and filamin were lost at the permeabilizing stage for both 
detergents and 30% of actin after Triton X-100 and 15% after saponin skinning. 
Subsequent cycles of contraction and relaxation resulted in accumulated loss, 
notably of myosin and filamin, so that after the third contraction as little as 2 0 % 
and 40% respectively of the original complement of these proteins remained in 
the muscle strips. These changes in protein composition were accompanied by 
a drastic redistribution of the proteins in the muscle cells, most notably of 
myosin.
Another method of permeabilizing, first reported in 1979 by Cassidy, Hoar 
and Kerrick, has recently become more widely used (Nishimura et al; 1988;
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Kitazawa et al; 1989). This involves alpha-toxin, a transmembrane pore-making 
exoprotein produced by Staphylococcus aureus. Alpha-toxin (Mol. wt. 33 000) 
binds to cell surfaces and forms hexamers with other toxin molecules which 
insert into the plasma membrane to form pores of 2-3 nm diameter. The 
limited pore size allows equilibration of the cytoplasm with inorganic ions and 
small molecules such as ATP and EGTA but prevents the passage of proteins 
(including alpha-toxin itself) into and out of the cell. This technique has the 
advantage over the other techniques that the membrane bound receptors remain 
intact. This has allowed these workers to investigate the second messenger and 
G-protein transduction mechanisms.
The aim of the study undertaken in this chapter was to contrast and 
compare treatment with (1) saponin; (2) EGTA and (3) alpha-toxin as methods 
for permeabilizing the sarcolemma of rat anococcygeus muscle strips.
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MATERIALS AND METHODS
PREPARATION
The preparation used throughout was the anococcygeus muscle of the rat. 
This was harvested and mounted on the tension measurement system as 
described in Section B (Permeabilized Muscle) of Chapter 2.
SOLUTIONS
The composition of the solutions used and the method used to prepare 
them are detailed in Section B Chapter 2. The solution composition is given in 
Table 2.3. Ionic strength was altered by varying the amount of KC1 in the 
solution.
CALMODULIN
It has already been stated in the introduction that it is essential to have 
calmodulin present in the bathing medium of saponin-treated preparations to 
obtain reproducible contractions in response to calcium. Calmodulin is, however, 
very expensive from commercial sources. For this reason the calmodulin used 
in the experiments detailed in the results section was made at the National 
Institute of Medical Research, Mill Hill, London under the tutelage of Dr. 
Katalin Torok.
Calmodulin is extracted in two stages, first all proteins are extracted and 
secondly all proteins that bind calcium are extracted. The protein is extracted 
from bovine brain by first homogenizing the brain. The homogenate is then
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centrifuged (1400 r.p.m. for 20mins at 4°C). The supernatant is then mixed with 
cellulose gel. Cellulose binds any proteins which are in the supernatant. 
Calmodulin and like proteins are removed from the cellulose by running a salt 
gradient, with a pH of 5.9, through the cellulose which has now been packed 
into a column. The effluent from the column is collected by a fraction collector. 
The fractions which contained protein (this was detected by a dual wavelength 
spectrophotometer scanning at 265nm and 280nm) were then mixed with 
phenylsepharose which had 0.5mM calcium added to it. This mixture, of 
fractions, phenylsepharose and calcium, is then added to a column. Any 
calmodulin present in the fractions from the cellulose column will bind to the 
calcium within the phenylsepharose. To remove the calmodulin an EGTA 
containing solution is passed down the phenylsepharose column. EGTA is able 
to remove calmodulin from the column because of its ability to bind calcium. 
Again, fractions are collected by a fraction collector and the protein content 
measure by a dual wavelength spectrophotometer set at 265nm and 280nm. The 
fractions containing protein are then freeze dried until they become a fine 
powder.
An assay for calmodulin is used at all the stages of the extraction. Also, 
at the end of the extraction procedure the protein that is suspected to be 
calmodulin is tested against a protein known to be calmodulin using gel 
electrophoresis.
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PERMEABILIZATION TECHNIQUES
(1) Saponin: the mounted strip of muscle was exposed in ’0.2 relaxing’ 
solution to 50/zg/ml saponin for 30 minutes and then washed several times in ’0.2 
relaxing’ solution.
(2) EGTA: the muscle strips were bathed in the following solution for 4 
hours at a temperature of 4°C. The solution contained (mM): K, 130; Na, 40; 
ATP, 5; EGTA, 10 and HEPES, 25. The concentrations of free [Ca2+] and 
[Mg2*1"] resulting from contamination was InM and 1.2^M respectively (Smith, 
1985). The solution had a pH of 7.0. The EGTA-treatment was similar to a 
procedure developed for cardiac muscle by McClellan and Winegrad (1978). 
After treatment the muscle was mounted and further treated as described in 
Chapter 2, Section B.
(3) Toxin: Figure 3.1 A shows an example of the tension response during 
the protocol used to permeabilize the mounted strips of rat anococcygeus 
muscle. The strip of anococcygeus was initially exposed to 30/iM noradrenaline 
while in Tyrode’s solution. This caused a contraction in the muscle which was 
maintained until the noradrenaline was removed. The preparation was then 
placed in a mock intracellular solution (63/xM Ca2+) which caused a transient 
contraction. After 10 minutes in this solution, alpha-toxin from Staphylococcus 
aureus (2mg/ml) was added. This caused a slow rise in tension which eventually 
reached a plateau. Tension presumably rose as a result of the toxin forming
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Figure 3.1 shows the solution protocol used to toxin-permeabilize rat 
anococcygeus muscle. The solution changes are indicated by the hatched bars 
below each tension record. In Panel A the solution changes include the addition 
of crude alpha-toxin (2mg/ml) and in Panel B alpha-toxin was omitted from the 
bathing medium.
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pores in the surface membrane enabling calcium to gain access to the contractile 
proteins. Once tension had reached a plateau the toxin was removed. This 
produced little change in tension. On the other hand, lowering the [Ca2+] 
caused a rapid relaxation. Subsequent exposure of the muscle to caffeine or 
noradrenaline caused a transient contraction. Panel B of Figure 3.1 shows the 
response of another strip of anococcygeus muscle subjected to a similar protocol, 
but without the toxin. Under these circumstances lowering [Ca2+] had little 
effect, and neither caffeine nor noradrenaline caused a significant response 
compared with that illustrated in panel A.
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RESULTS
IS THE MUSCLE PERMEABILIZED?
Reuben and Wood (1979) listed some criteria to help determine whether 
a muscle was permeabilized. These were:
( 1 ) that development of rigor and relaxation from rigor should occur within 
seconds of MgATP removal or addition;
(2) the responses of chemically skinned fibres to variations in low MgATP 
concentrations should be identical to those of mechanically skinned fibres; and
(3) the responses of chemically skinned fibres measured in (1) or (2) should not 
be quantitatively affected either by mechanical removal of the sarcolemma or 
by treatment of the preparation with non-ionic detergents that destroy the 
sarcolemma.
Bearing the first of these three criteria in mind, I examined the effect of 
removing ATP and CrP from maximally calcium-activated muscles. This was 
carried out on up to six muscles which had previously been treated in the 
following way: (A) exposed to ’0.2 relaxing’ solution without any agents to cause 
permeabilization, hence the sarcolemma was intact in these muscle strips; (B) 
saponin-treated; (C) EGTA-treated and (D) alpha-toxin-treated. As shown in 
Figure 3.2, raising the [Ca2+] from 0.08/iM to 63/xM caused a maintained 
contraction in all four types of treated muscle, 63/xM Ca2+ produces a maximal 
contraction to calcium. This is demonstrated for alpha-toxin-treated rat 
anococcygeus in Figure 4.8. Removing ATP and CrP produced a profound
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Figure 3.2 shows the effect of removing ATP and CrP (black bar) on maximum 
calcium-activated force (lOmM-total EGTA) in A. intact depolarised muscle; B. 
saponin-treated muscle; C. EGTA-treated muscle and D. alpha toxin-treated 
muscle. Changes in [Ca2+] are shown by the step lines under the trace.
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relaxation in the depolarised intact muscle (A). However, it caused a further 
contraction in the other three types of treated muscle. This further contraction 
was not maintained in any of the treated muscles. The muscles contracted 
transiently and then relaxed back to the previous tension level. This type of 
response has also been reported in saponin-treated preparations (Somlyo et al, 
1988; Itoh et al, 1986). The authors suggest that the tension produced in the 
absence of ATP and CrP is due to attachment of rigor crossbridges. When the 
[Ca2+] was lowered in the rigor solution the treated muscle did not relax. The 
muscles only relaxed when they were bathed in a solution containing ATP and 
CrP and a low [Ca2+]. The relaxation upon removal of ATP and CrP observed 
in the intact depolarised muscle has been observed by other workers and is 
thought to be the result of removing the purinoreceptor activation of these 
preparations (Gillespie, 1972; Burnstock et al, 1978).
The success of the various ’skinning’ techniques was further examined by 
measuring the responses of muscles to stimuli which are known to have a direct 
effect on the contractile proteins. The stimuli chosen were 100/iM cAMP and 
lOmM Pf. Both these compounds are known to suppress force in muscles 
which have either been skinned using Triton X-100 (Meisheri & Ruegg, 1983; 
Pfitzer et al, 1984; Ruegg & Pfitzer, 1985; Schneider, Sparrow &Ruegg; 1981; 
Gagelman & Guth; 1987) or saponin (Itoh et al, 1981; Itoh, Kanmura & 
Kuriyama, 1986). Four representative traces (one from up to six examples for 
each treatment) are shown in Figure 3.3 from (A) an intact muscle, i.e. a muscle 
which has received no treatment, (B) a saponin-treated muscle,
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Figure 3.3 shows the effect of 100/xM cAMP (unfilled bar) and lOmM phosphate 
(filled bar) on maximum calcium-activated force (lOmM-total EGTA) in A. 
intact depolarised muscle; B. saponin-treated muscle; C. EGTA-treated muscle 
and D. alpha toxin-treated muscle. Changes in [Ca2+] are shown by the step 
lines under the trace.
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(C) EGTA-treated muscle and (D) an alpha-toxin-treated muscle. The muscles 
were first maximally calcium-activated and all four muscles contracted when 
[Ca2+] was raised. The calcium-channel blocker nifedipine (10/xM) inhibited the 
calcium-activated tension developed by the intact preparation, but had no effect 
on either saponin- or EGTA-treated preparations (results not shown). Both 
lOO/iM cAMP and lOmM P, cause a fall in tension in all the treated muscles, 
however, they had no effect in the intact depolarised muscle. The rate of 
relaxation in response to 100/iM cAMP was similar in all the muscles, but the 
rate of relaxation observed with lOmM P, was slower in EGTA-treated muscle 
than in the other two types of treated muscle.
A common method to check if the muscle is completely permeabilized, 
based on an observation made in saponin-skinned smooth muscle, is to examine 
whether the muscle is still responsive to agonist stimulation. Itoh, Kuriyama and 
Suzuki (1983) reported that fully permeabilized rabbit mesenteric artery was no 
longer able to respond to noradrenaline. Figure 3.4 shows how the different 
muscles respond to noradrenaline after they have been treated. Only the 
saponin-treated muscle failed to respond to noradrenaline. The response to 
noradrenaline seen in EGTA- and toxin-treated muscle was similar to that of 
the intact muscle and suggests that these treatments leave receptors functional 
as has been reported by Nishimura et al (1988) and Kitazawa et al (1989) for 
alpha-toxin permeabilized vascular smooth muscle.
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Figure 3.4 shows the response to 30/xM noradrenaline (NA, unfilled bar) in the 
presence of 0.08/xM calcium (0.2mM-total EGTA) in A. intact depolarised 
muscle; B. saponin-treated muscle; C. EGTA-treated muscle and D. 
alpha-toxin-treated muscle.
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AN EXAMINATION OF THE REDUCTION IN MAXIMUM CALCIUM ACTIVATED-FORCE 
IN SAPONIN-, EGTA- AND ALPIIA-TOXIN-TREATED SMOOTH MUSCLE
This part of the study was undertaken to examine and compare the decline 
in the amplitude of maximum calcium-activated force (Tmax) in rat 
anococcygeus. An attempt was also made to prevent this decline in saponin- 
and alpha-toxin-treated muscle. These experiments were all carried out in the 
same manner: after the muscle had been treated, it was maximally activated by 
raising the [Ca2+] (63^M) in the bathing medium. The muscle was induced to 
contract for 1 0  minutes and then it was relaxed for 1 0  minutes by lowering the 
[Ca2+] in the bathing medium. This was repeated either 6  or 10 times. The 
individual experiments were all carried out on up to 6  different muscle strips. 
Figure 3.5A shows a series of maximum calcium-activated contractions in an 
alpha-toxin permeabilized smooth muscle. The [Ca2+] was changed as indicated 
below the tension record. It can be seen that the time course of the 
calcium-activated contractions changes as the contraction amplitude decays. This 
is best exemplified when the contractions are superimposed (Figure 3.5B). This 
effect was also seen in saponin-permeabilized muscle (data not shown). The 
change in time course is unlikely to be due to a reduced calcium sensitivity 
because raising the [Ca2+] above 63/xM, after the amplitude of the contractions 
evoked by calcium had declined, did not produce any more tension.
Figure 3.6 shows the decline in the amplitude of Tmax after the three 
different permeabilization techniques. The decline is greatest in saponin-treated 
muscle. Tension has fallen to a mean value of less than 20% by the 6 th 
contraction. Tmax also declines in alpha-toxin-treated muscle, but not to the
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Figure 3.5A shows the decline in the amplitude of maximum calcium-activated
force upon repetitive application of calcium in an alpha-toxin permeabilized rat
anococcygeus muscle strip. The changes in [Ca2+] are shown as steps
underneath the tension record. Figure 3.5B shows three sample tension
responses to repetitive exposure to calcium (shown by the step line below the
traces) from the same muscle as used in Panel A. 1st, 4th and 8 th indicate the
number of the contraction in the repeat protocol.
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Figure 3.6 shows the decline in maximum calcium-activated force expressed as 
a percentage of the first maximum calcium-activated contraction for 
saponin-treated (open circle), EGTA-treated (open square) and 
alpha-toxin-treated (open triangles) muscle strips. (mean±S.D. n=3-6).
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same extent as in saponin-treated muscle. Tension falls to approximately 50% 
by the 5th contraction and even by the 10th has not fallen below 40%. 
EGTA-treated muscle shows no reduction in Tmax. However, the mean 
maximum tension produced by calcium in EGTA-treated muscle was only a third 
of that produced by saponin-treated muscle. Figure 3.7 shows the individual 
tensions produced by the first contraction in response to calcium in the three 
different treated muscles. EGTA-treated muscle produce less tension than 
either saponin or alpha toxin-treated muscle and saponin-treated muscle 
produces less than alpha-toxin-treated muscle. In preparing the EGTA-treated 
muscles the success rate was very low - only one in three muscle strips were 
responsive enough to calcium to allow further experimentation.
Further experiments were carried out to study the characteristics of the 
decline in Tmax. The decline might be a function of the number of 
contractions, or simply the time after saponin-treatment. In order to distinguish 
between these two possibilities a saponin-treated muscle was activated, allowed 
to relax, then activated again one hour later. The reduction in the size of the 
contraction was compared with that in the preparations which had been 
repeatedly contracted and relaxed for one hour. The results shown in Figure 
3.8 indicate that the fall in the size of the contracture was independent of 
whether the muscle had been activated during this period. This result is 
consistent with the hypothesis that the fall in force is due to the steady loss of 
a factor from the preparation with time rather than some accumulating damage 
as a result of repeated cycles of activation and relaxation.
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Figure 3.7 shows the peak tension (mN) produced by the initial maximum 
calcium-activated contraction in saponin-treated, EGTA-treated and 
alpha-toxin-treated muscle strips.
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Figure 3.8 compares the decline of maximum calcium-activated force in 
saponin-treated preparations during repetitive contractions in response to 
calcium (open circles) or which have contracted once, allowed to relax and then 
contracted again (filled squares) one hour later. (mean±S.D. n=3-6)
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As mentioned in the introduction to this chapter, the cytosolic protein 
calmodulin had been reported to enhance calcium-activated force and its loss 
from the preparation might be responsible for the decay in calcium-activated 
force. The decline in Tmax in saponin-treated rat anococcygeus was, therefore, 
examined in the presence of 1/jM calmodulin. Figure 3.9A shows that 
calmodulin only had a small effect on the decline. These experiments were 
carried out at an ionic strength of 0.2M. Since calcium’s affinity for calmodulin 
is increased at lower ionic strengths (Wolff et al, 1977) the next set of 
experiments was carried at an ionic strength of 0.07M. The results in figure 
3.9B show that this procedure slows the decline, but does not prevent it. If 
calmodulin (1/iM) (Figure 3.9C) is present in the solutions with a lower ionic 
strength, the decline is still slower. Other interventions were tried which failed 
to have any effect on the decline. These included experiments using solutions 
with ( 1 ) a pH of 6 . 8  or 7.4 to examine the pH used by other workers and (2) 
a higher ionic strength - (0.27M) to examine whether this had the opposite 
effect to low ionic strength.
The decline in the amplitude of Tmax toxin-treated muscle was less than 
that in saponin-treated muscle. The decline in alpha-toxin-treated muscle was 
prevented at an ionic strength of 0.07M. This is shown in figure 3.10.
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Figure 3.9 A, B & C show the decline in maximum calcium-activated force 
expressed as a percentage of the first maximum calcium-activated contraction in 
saponin-treated muscle. Panel A shows the decline in muscles bathed in 
solutions with (closed circles) and without (open circles) calmodulin (1/xM) 
present in the bathing solution (mean±S.D. n= 3-6 ). Panel B shows the decline 
in muscles bathed in solutions with an ionic strength of 0.2M (open circles) and 
0.07M (closed triangles) (mean±S.D. n=3-6. Panel C shows the decline in 
muscles bathed in solutions with (i) an ionic strength of 0.07M which contain 
calmodulin (l/iM)(closed squares) or (ii) an ionic strength of 0.2M which do not 
contain calmodulin (ljuM) (open circles) (means±S.D. n=3-6).
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Figure 3.10 shows the decline in maximum calcium-activated force expressed 
as a percentage of the first maximum calcium-activated contraction in 
alpha-toxin-treated muscle bathed in solutions with an ionic strength of 0.2M 
(open triangles) and an ionic strength of 0.07M (closed triangles). (mean±S.D., 
n=3-6).
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The size of the initial maximum calcium-activated contraction altered as 
the conditions used to examine the repetitive calcium-activated force were 
changed. These are summarised in Figure 3.11. Mean tension produced at low 
ionic strength (0.07M) was higher than that produced at the higher ionic 
strength (0.2M) (0.5mN to 0.8mN). Calmodulin increased this further to l.OmN. 
Toxin-treated muscle had a mean tension of 0.8mN and this was increased to 
l.OmN at an ionic strength of 0.07M.
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Figure 3.11 shows the peak tension (mN) produced by the initial maximum 
calcium-activated contraction after saponin-treatment (1-4) and 
alpha-toxin-treatment (5 & 6 ) with the following alterations to the skinning and 
activating solutions: (2) 1/xM calmodulin; (3) ionic strength of 0.07M; (4) 1 /iM 
calmodulin and an ionic strength of 0.07M; and (6 ) ionic strength of 0.07M.
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DISCUSSION
The aim of the work described in this section was to compare three 
potential permeabilization techniques and to decide which was best for further 
use. The first problem was to test whether the different techniques actually 
permeabilized the muscle. The effectiveness of the three permeabilizing 
techniques was established by comparing the responses from the permeabilized 
muscles with those from the intact muscle. Bathing the intact muscle in a mock 
intracellular solution depolarised the muscle. The muscle now contracted in 
response to extracellularly applied calcium. The ’treated’ muscles also contracted 
in response to externally applied calcium. However, unlike the other muscles 
the intact muscle only contracted in response to a [Ca2+] which maximally 
contracted the treated muscles i.e. 63/iM. This contraction could be blocked by 
application of 1/iM Nifedipine which is known to block voltage operated calcium 
channels (Spedding, 1987). The results imply that the major route for calcium 
entry in intact preparations is via voltage operated calcium channels. This is in 
contrast to the maximum calcium-activated force produced by the other three 
permeabilizing techniques, which was not affected by nifedipine.
All three of the ’treated’ muscles responded to removal of ATP and CrP 
in a manner which satisfies the criteria of Reuben and Woods’ (1979) for a 
’skinned’ muscle. That is, they all contracted when ATP and CrP were 
removed from the bathing medium and remained contracted when the [Ca2+] 
was lowered in the rigor solutions. This indicated that the muscles had formed
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rigor crossbridges. Again this was very different to the way in which the intact 
muscle responded; where removal of ATP and CrP caused relaxation and 
addition of ATP caused a transient contraction. The ’treated’ muscles also 
responded very differently to cAMP and Pz- from the intact depolarised muscle. 
Both agents are known to act on the contractile proteins and cause a reduction 
of maximum calcium-activated force. No relaxation was evoked in intact 
preparations, but did occur in the permeabilized muscles. The EGTA-treated 
muscle did, however, respond differently from the others, as shown in Figure 3.2, 
being slower to respond to Pz and calcium than the others. This might be 
explained if the apparent diffusion coefficient was lower after EGTA-treatment. 
Similar behaviour was reported in EGTA-treated cardiac muscle (Kentish & 
Jewell, 1984; Miller & Smith, 1985). The lower diffusion coefficient in 
EGTA-treated muscle to Pz might also explain why it is slower to respond to 
calcium and produced less tension than saponin- or toxin-treated preparations, 
the muscle may be accumulating Pz- which will depress calcium-activated force.
Another method to determine the extent of permeabilization in 
saponin-treated muscle was to examine the response to noradrenaline. Itoh et 
al (1983) noted that once the muscle was completely permeabilized (i.e. the 
permeabilized muscle was producing the same degree of tension in response to 
Ca2+ as the intact muscle in response to K+) that the response to 
noradrenaline was abolished. They used this as a measure of the degree of 
permeabilization. In the present study the response to noradrenaline was 
abolished only after saponin-treatment, but persisted after both EGTA- and
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alpha-toxin-treatments. Nishimura et al (1988) and Kitazawa et al (1989) had 
both previously reported that alpha-toxin permeabilized vascular smooth muscle 
retains its ability to respond to noradrenaline. The present study is the first 
report that EGTA-treated muscle also retains functional membrane bound 
receptors.
The fact that alpha-toxin-treated anococcygeus smooth muscle retains 
functional membrane bound receptors is not evidence that the muscle is not 
permeabilized. Unlike the intact muscle, alpha-toxin-treated muscle can contract 
repeatedly upon noradrenaline exposure (e.g. Figure 4.5). The intact muscle 
cannot contract more than once, probably because the bathing [Ca2+] is too low 
to allow the intracellular stores to load. This experiment of evoking repeat 
contractions in response to noradrenaline was not attempted in EGTA-treated 
muscle. Hence it is more difficult to claim that the muscle is permeabilized 
even although it can respond to noradrenaline. However, the evidence from the 
ATP, cAMP and P, experiments suggest that the muscle is permeabilized
It is not known why saponin-treated muscle loses its ability to respond 
to noradrenaline and other agonists. There are several possibilities:
( 1 ) as saponin removes the cholesterol from the surface membrane this might 
dislodge the protein receptors or inactivate them;
(2 ) the second messengers produced by the agonists which promote the signal 
internally, for example Ins(l,4,5)P5, diacylglycerol (DG) and cAMP, are produced 
from membrane-bound precursors which might be lost during saponin-treatment.
The different responses of these three types of ’treated’ muscle to
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noradrenaline could be connected with the differences in the rate and extent of 
the decline in Tmax. The larger the ’pores’ produced by the permeability 
treatment, the greater the chance of a loss of receptor function and the more 
extensive the loss of essential cytosolic proteins and thus of calcium-activated 
force. The change in time course of Tmax might also be explained by the 
gradual loss of cytosolic enzymes and other proteins. The amplitude of Tmax 
declines more slowly in toxin-treated muscle and not at all in EGTA-treated 
muscle and toxin-treated muscle at low ionic strength. The decline in 
saponin-treated preparations is reduced by including calmodulin in the bathing 
media, indicating that it is being lost from the muscle during this permeabilizing 
technique. Employing conditions which improve the affinity of calmodulin for 
calcium (i.e. lowering ionic strength) has a similar beneficial effect. Kossman 
et al (1987) have already shown that saponin-treatment allows the loss of 
proteins from the muscle. The slower decline observed in toxin-treated muscle 
can probably be attributed to the fact that it produces smaller ’pores’ in the 
membrane than saponin. This interpretation has been proposed by Thelestam 
and Mollby (1979) who examined 38 cytolytic agents, including saponin and 
alpha-toxin from Staphylococcus aureus. They attempted to classify the different 
agents on the basis of their effect upon the leakage pattern of three different 
labels; nucleotides, alpha-aminoisobutyric acid and R N A  Saponin was found to 
produce ’pores’ in the membranes of human fibroblasts which allowed equal 
leakage of the high molecular weight RNA and the lower molecular weight 
nucleotides and alpha-aminoisobutyric acid. Alpha-toxin-treatment, on the other
72
hand, only resulted in the leakage of the lower molecular weight molecules 
(nucleotides and alpha-aminoisobutyric acid) and retained the higher molecular 
weight RNA. This would indicate that saponin produces larger ’pores’ in the 
membrane than alpha-toxin. The ’pores’ produced by alpha-toxin have been 
measured to be 2-3nm in diameter (Fussle et al, 1981; Ikigai & Nakae, 1987) 
which would allow the free diffusion of molecules with a molecular weight of 
less than 4000. Consequently, the toxin itself cannot enter and the contractile 
proteins and calmodulin cannot be lost (Hohman, 1988).
Using a lower ionic strength of 0.07M helped to minimise the decline in 
the amplitude of Tmax. This could indicate that an ionic strength of 0.2M was 
higher than the muscle’s natural ionic strength or it might mean that some other 
factor which normally increases calmodulin’s affinity for calcium has also been 
lost from toxin- and saponin-treated muscle. At low ionic strength (0.07M), 
toxin-treated muscle behaved like EGTA-treated muscle which might indicate 
that any such factor lost which naturally increases calmodulin’s affinity for 
calcium is not lost from EGTA-treated muscle. Other factors obviously need to 
be restored to saponin-treated preparations to prevent completely the decline 
in the size of Tmax. Some possible candidates are myosin, actin, phosphatases 
and protein kinase C.
In conclusion, all three techniques appear to permeabilize muscle. 
However, they have different properties and suitability for further 
experimentation. These different properties arise because each technique 
produces different sized ’pores’ in the surface membrane. Saponin appears to
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produce the largest. This results in the loss of agonist-induced responses and 
a rapid decline in the amplitude of Tmax. The reduction can only be partially 
prevented by including the (expensive) protein calmodulin to the bathing 
solutions and using low ionic strength to favour its affinity for calcium. 
Toxin-treatment produces the next largest ’pores’. Such muscles retain their 
ability to respond to agonist stimulation and low ionic strength is sufficient to 
prevent the decline in the amplitude of Tmax. EGTA-treatment of muscle 
appears to produce the smallest ’pores’ and also to retain its ability to respond 
to agonist stimulation, showing no decline in the amplitude of Tmax. However, 
EGTA-treated muscle only produces a third of the tension produced by 
equivalent saponin- or toxin-treated muscles. Overall, alpha-toxin-treated muscle 
was considered to be the most suitable permeabilization technique and was used 
throughout the rest of the study.
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CHAPTER 4
THE EFFECT OF GTP ON NORADRENALINE- AND 
CALCIUM-ACTIVATED FORCE IN ALPHA-TOXIN 
PERMEABILIZED SMOOTH MUSCLE FROM 
GUINEA PIG PORTAL VEIN AND RAT ANOCOCCYGEUS.
INTRODUCTION
The involvement of guanosine triphosphate (GTP) in transmembrane 
signalling is a fairly recent discovery. It was in 1971 that Rodbell et al reported 
that GTP was required for hormonal activation of adenylyl cyclase. Shortly after 
this Harwood, Low and Rodbell (1973) showed that GTP in the presence of 
several hormones could both stimulate and inhibit adenylyl cyclase and that this 
effect could also be produced by Gpp(NH)p, a non-hydrolysable analogue of 
GTP. It was discovered that a protein was involved when Pfeuffer (Pfeuffer & 
Helmriech, 1975; Pfeuffer, 1977) using GTP-sepharose chromatography was able 
to partially resolve a protein fraction that conferred regulatory properties on 
adenylyl cyclase. At around the same time Ross and Gillman (1977, 1980) 
showed that a protein extracted from plasma membranes would confer guanine 
nucleotide-mediated regulation of adenylyl cyclase to membranes devoid of this 
activity. This protein has since been purified "(Northup et al, 1980; Stenweis et 
al, 1981) and is termed the G-protein. Cassel and Selinger (Cassel & Selinger, 
1977, 1978; Cassel, Levkowitz & Selinger, 1977) demonstrated that hormones 
working through adenylyl cyclase stimulate the exchange of GTP for GDP 
through a cholera toxin-sensitive GTPase. This has led to the confirmation that 
activation of adenylyl cyclase involved the concerted action of three proteins, the 
stimulatory hormone receptor, the catalytic protein and a G-protein. It was 
proposed that the activated agonist receptor complex forms a ternary complex 
with the G-protein (Kent, Delean & Lefkowitz, 1980; Stadel, Delean &
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Lefkowitz, 1982) that results in the exchange of GTP for GDP. The activated 
G-protein then combines with the inactive enzyme to form the active enzyme 
species. The lifetime of this active complex is determined by the GTPase 
activity that is inherent in the G-protein. Conversion of GTP to GDP by the 
GTPase returns the active enzyme and G-protein to an inactive one (Cassel et 
al, 1977). That is, stimulatory hormones promote an ’on’ reaction that involves 
the exchange of GTP for GDP, and GTPase activity catalyses an ’off reaction. 
The marked activation of adenylyl cyclase afforded by stable analogues of GTP 
(Rodbell et al, 1971) can therefore be explained by their resistance to hydrolysis 
by the GTPase which prolongs the steady-state level of the activated enzyme.
G-proteins exist as a-p-y heterotrimer (Northup et al, 1980; Sternweis et 
al, 1981; Bokoch et al, 1983,1984; Codina et al, 1983). The a-subunit contains 
the GTP-binding site and the GTPase activity. The ,8 -subunit and 7 -subunit are 
usually found in tight association even under activating conditions. It is the 
a-subunit which varies in size amongst the different G-proteins. On the whole 
the p- and 7 - subunits are essentially the same in the different G-proteins. In 
the non-activated cell the G-protein consists of GDP bound to an associated 
heterotrimer (Ga-£-7 .GDP). When the hormone binds to the receptor (HR) it 
causes the dissociation of Ga-0 -7 .GDP (Brandt & Ross, 1986) and association 
of GTP to give HR.Ga.GTP + G^-7 . The HR binding also causes an increase 
in the intrinsic GTPase activity. The dissociation of the G-protein subunits 
promotes the dissociation of the HR (Hekman et al, 1984). The Ga.GTP 
complex binds to and activates the enzyme. This activation is switched off by
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the conversion of GTP to GDP and reconstitution of the G-protein subunits is 
promoted (Rojas & Birnbaumer, 1985).
There are at least four different G-proteins which appear to control several 
enzyme systems. More than one agonist cooperates with each G-protein. The 
four main functions regulated by G-proteins are:
( 1 ) activation of adenylyl cyclase;
(2 ) inhibition of adenylyl cyclase;
(3) stimulation of retinal cyclic GMP phosphodiesterase and;
(4) stimulation of phosphoinositide hydrolysis.
These functions are reviewed by Gillman (1987). For the purposes of this 
chapter I will concentrate on the G-protein interaction with the last of these 
functions - stimulation of phosphoinositide hydrolysis.
Many hormones mobilise intracellular stores of calcium by virtue of their 
ability to stimulate the phosphodiesteratic cleavage of phosphatidylinositol(4,5) 
bisphosphate (PtdIns(4,5)P2) to yield inositol(l,4,5)triphosphate (Ins(l,4,5)Pj) 
and diacylglycerol (DG) (reviewed by Berridge & Irvine, 1984; 1989). The 
phosphatidylinositol cycle will be discussed in Chapter 5. By 1985 it was evident 
that a G-protein was involved in controlling the enzyme (phospholipase C) which 
splits PtdIns(4,5)P2  to give Ins(l,4,5)P5  and DG. The first reports of GTP’s 
involvement was made by Gomperts (1983) who demonstrated that, in 
permeabilized mast cells, GTP stimulated a calcium-dependent secretion of 
histamine. He proposed that a guanine nucleotide binding protein was involved 
in calcium-dependent secretory events. Haslam and Davidson (1984a;b) showed
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that guanine nucleotides reduced the calcium requirement for thrombin 
stimulation of secretion in permeabilized platelets and enhanced the response 
to thrombin with respect to both secretion and diacylglycerol formation.
Litosch, Wallis and Fain (1985) demonstrated that, in membranes prepared 
from blowfly salivary glands, 5-hydroxytyptamine (5-HT) stimulated the 
breakdown of endogenous [JH] inositol-labelled phosphoinositides by 
phospholipase C. This stimulatory effect of the hormone was dependent on the 
addition of guanine nucleotides. GTP, Gpp(NH)p and GTP-7 -S potentiated the 
effect of 5-HT. The non-hydrolysable analogues of GTP, GTP-7 -S and 
Gpp(NH)p, activated basal phospholipase C activity. Cockcroft and Gomperts 
(1985) also found that breakdown of endogenous polyphosphoinositides, in 
human neutrophil membranes, was stimulated by GTP-7 -S. Subsequently, 
guanine nucleotide stimulation of membrane phospholipase C activity utilizing 
labelled endogenous substrate has been demonstrated for a number of different 
tissues and cells including GHj pituitary cells (Lucas et al, 1985), hepatocytes 
(Wallace & Fain, 1985a,b), polymorphonuclear leucocytes (Smith et al, 
1985,1986,1987), cerebral cortex (Gonzales & Crew, 1985) and pig coronary 
artery (Sasaguri, Hirato & Kuriyama, 1985).
The reported characteristics for guanine nucleotide activation of membrane 
phospholipase C are strikingly similar in the studies cited. GTP itself was found 
to be a weak activator, even at high concentrations (Cockcroft & Gomperts, 
1985; Litosch et al , 1985; Lucas et al, 1985; Smith, Cox & Snyderman, 1986) 
and GDP, GMP, ATP, ADP and AMP were completely ineffective. In contrast,
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non-hydrolysable guanine nucleotides were potent activators of phosphoinositide 
hydrolysis. GTP-7 -S was found to be the most effective nucleotide tested 
(Cockcroft & Gomperts, 1985; Litosch et al , 1985; Lucas et al, 1985). GTP 
activation of phospholipase C activity was found to be competitively inhibited by 
a stable GDP analogue, GDP-^-S (Cockcroft, 1986; Uhing et al, 1986; Martin 
et al, 1986; Cockcroft & Taylor, 1987), which suggests that activation of 
phospholipase C is associated with the binding of GTP, with the GDP-bound 
state being inactive.
Since the discovery that GTP has a regulatory role in releasing calcium, 
much interest has been shown in its effect on calcium release and 
calcium-activated force. Dawson (1985) reported in liver microsomes, which 
were normally insensitive to Ins(l,4,5)P5, that preincubating the microsomes with 
GTP and polyethylene glycol (PEG) (3%) increased the preparation’s sensitivity 
to Ins(l,4,5)P3. However, GTP alone caused a release of calcium via a 
mechanism that was independent of Ins(l,4,5)Pj. This effect was abolished if 
PEG was omitted from the solution. Gill and Mullaney have further developed 
these results (Gill et al, 1986; Chueh et al, 1987; Mullaney et al, 1988 and 
reviewed in Gill, Mullaney & Ghosh, 1988) in permeabilized neuronal and 
smooth muscle cell lines. These workers showed that the calcium which was 
released by GTP alone appears to have come from the Ins(l,4,5)Pr sensitive 
store. This effect of GTP cannot be mimicked by GTP-7 -S or any of the other 
nonhydrolysable analogues of GTP. In fact GTP-7 -S blocks the response to 
GTP. GTP was also found to increase calcium uptake in the presence of
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oxalate in permeabilized neuronal and smooth muscle cell lines at the same 
concentration as it promotes release. Finally they concluded that GTP has a role 
to play in transmembrane conveyance of calcium and, since this involves the 
Ins( 1,4,5)Pj-releasable pool GTP may control the size of this calcium store. The 
one drawback to this hypothesis is the need for PEG to obtain the effect of 
GTP. Thomas (1987) showed in permeabilized hepatocytes, without PEG, that 
GTP did not release calcium alone but did potentiate the calcium released by 
Ins(l,4,5)P5. However, again this effect was not mimicked by GTP-7 -S.
The work carried out in permeabilized smooth muscle has largely disagreed 
with the work of Dawson and Gill. In saponin-, alpha-toxin- and ^-escin-treated 
muscle, GTP alone does not cause any substantial release of calcium (Kobayashi, 
Somlyo & Somlyo, 1988a; Kitazawa et al, 1989; Nishimura, Kobler & van 
Breemen,1988: Kobayashi et al, 1989). However, GTP-7 -S has been reported 
to release intracellular calcium in both saponin and alpha-toxin permeabilized 
muscle (Nishimura et al, 1988; Kobayashi et a/,1988a;b). This is also in 
contradiction to Gill and colleague’s work where GTP-7 -S inhibited the release 
of calcium. Saida and van Breemen (1987) and Saida et al (1988) have reported 
similar results to Thomas (1987) in which GTP was required before Ins(l,4,5)PJ 
could release calcium from the intracellular store. This calcium was also 
mobilised from the same store as the calcium released by caffeine. However, 
unlike Thomas (1987), Saida and van Breemen (1987) and Saida, Twort and van 
Breemen (1988) reported that GTP-7 -S could mimic the effect of GTP. These 
results by Saida et al (1987,1988) have not been found to be the universal case.
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Other workers using different smooth muscle preparations, both vascular and 
visceral, have shown that Ins(l,4,5)P3  can release calcium in the absence of GTP 
(Suematsu et al, 1984; Yamamoto & van Breemen, 1985; Kobayashi et 
a/,1988a;b; 1989; Kitazawa et al,1989).
Two important methodological developments for permeabilizing smooth 
muscle have been: ( 1 ) alpha-toxin from Staphylococcus aureus and (2) ^-escin. 
These methods retain functional membrane bound receptors (Nishimura et 
al, 1988; Kitazawa et al, 1989; Kobayashi et al, 1989), allowing these workers to 
analyse the role of GTP in agonist activation. Again, however, there have been 
conflicting results. Nishimura et al (1988) report that the response to 
noradrenaline can be obtained without the presence of GTP, whereas Kitazawa 
et al (1989) and Kobayashi et al (1989) reported that, to obtain reproducible 
responses to phenylephrine and carbachol, GTP was required. Although 
Nishimura et al (1988) showed that noradrenaline could produce a contraction 
without GTP being present, they did not investigate whether the response could 
be potentiated by GTP. The response initiated by GTP-7 -S could be partially 
blocked by heparin (Kobayashi et al, 1988) which is known to antagonise the 
Ins(l,4,5)P3  receptor (Worley et al, 1987). The response to Ins(l,4,5)P3  
(Kobayashi et al, 1988b), phenylephrine and carbachol (Kobayashi et al, 1989) 
were abolished by heparin. Where GTP has been shown to increase the 
response to the agonists GDP-/3-S has blocked this effect. Despite these 
differences in results, the bulk of the evidence suggests that G-proteins are 
involved in receptor signal transduction, leading to intracellular release of
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calcium and contraction in smooth muscle.
Much interest has also been paid to GTP’s effect on calcium-activated 
force. The first report was made by Kobayashi et al (1988a) who demonstrated 
in freeze-glycerinated rabbit main pulmonary artery that GTP or GTP-7 -S had 
no effect on the pCa tension curve. This, however, has been the only report of 
GTP and GTP-7 -S failing to affect calcium-activated force. All other studies 
have been made in muscle which has either been saponin-, alpha-toxin- or 
£-escin-treated. It has been universally agreed that, in these muscles, GTP or 
GTP-7 -S increases calcium sensitivity (Nishimura et al, 1988; Kobayashi et al, 
1988b; 1989; Kitazawa et al, 1989; Fujiwara et al, 1989). This effect is similar to 
increases in calcium-activated force produced by phenylephrine (Kitazawa et 
al,1989), and the effect of GTP on calcium-activated force is potentiated by 
noradrenaline (Nishimura et al, 1988). However, there is disagreement about 
what happens to maximum calcium-activated force (Tmax). Nishimura et al 
(1988) and Fujiwara et al (1989) report that GTP has no effect on Tmax, 
whereas Kitazawa et al (1989) and Kobayashi et al (1989) found that GTP-7 -S 
increases Tmax. There is much speculation about what causes the increase in 
calcium-activated force. The effect can be blocked by GDP-^-S, indicating that 
a G-protein is involved. However, it cannot be blocked by heparin indicating 
that Ins(l,4,5)P3  release of calcium is not a prerequisite for the effect. This 
suggests that GTP-7 -S activates phospholipase C via a G-protein producing 
Ins(l,4,5)P3  and DG from PtdIns(4,5)P2. It is DG that then activates protein 
kinase C which in turn phosphorylates the contractile proteins, increasing their
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sensitivity to calcium. Fujiwara et al (1989) have shown that GTP-7 -S promotes 
increased phosphorylation of the myosin light chain and increases shortening 
velocity. However, the authors were not convinced that this was due to protein 
kinase C because, although activation of protein kinase C by a phorbol ester 
increases calcium sensitivity it depresses Tmax, this is unlike the effect of 
GTP-7 -S, which either has no effect on Tmax or increases it. Another possible 
explanation of GTP-7 -S increase in Tmax is that it inhibits the inhibitory 
phosphatases which normally dephosphorylate the myosin light chain (Somlyo et 
al,1989).
To summarise, from this work on permeabilized smooth muscle: There 
seems reasonable agreement that a G-protein is involved in the agonist 
transduction mechanism. This appears to be mediated through the Ptdlns cycle. 
There is some evidence that GTP-7 -S causes calcium release via Ins(l,4,5)Pj and 
increases calcium-activated force via DG.
The aim of this study was to compare and contrast the effect of GTP on 
noradrenaline- and calcium-activated force in an alpha-toxin permeabilized 
visceral (rat anococcygeus) and a vascular (guinea pig portal vein) smooth 
muscle.
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MATERIALS AND METHODS
PREPARATIONS
Rat anococcygeus and guinea pig portal vein were isolated and prepared 
as described in Chapter 2. Each was set up in the experimental apparatus as 
described in Chapter 2 - Permeabilized Muscle. The muscle strips were 
permeabilized using alpha-toxin from Staphylococcus aureus as described and 
demonstrated in Chapter 3 and Figure 3.1.
SOLUTIONS
The solutions used were prepared as described in Chapter 2 - 
Permeabilized Muscle. The solution compositions are given in Table 2.3 and the 
drugs used are detailed in Table 2.2. The potassium salt used was potassium 
methansulphonate. The pH was set at 7.1 and the ionic strength at 0.2M.
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RESULTS
PROBLEMS ASSOCIATED WITH ALPHA-TOXIN PERMEABILIZATION IN RAT 
ANOCOCCYGEUS
Permeabilization with alpha-toxin from Staphylococcus aureus retains 
functional membrane bound receptors (Nishimura et al,1988; Kitazawa et al; 
1989). Kitazawa showed that both alpha adrenoreceptors and muscarinic 
receptors were retained. These features were tested for in rat anococcygeus. 
The results are shown in Figure 4.1. The muscle was permeabilized as 
described in Chapter 3 and thereafter proved responsive to calcium, 
noradrenaline and caffeine. The calcium stores were loaded in the experimental 
muscle by raising the [Ca2+]. This caused a contraction, the end portion of 
which can be seen in Figure 4.1. The [Ca2+] was lowered to 0.08/iM and the 
muscle relaxed. The muscle was then exposed to 30/xM noradrenaline and the 
muscle contracted transiently. However, the muscle did not respond when 
exposed to acetylcholine (3mM). The response of the intact muscle to 
acetylcholine was then investigated (Figure 4.2). The muscle was bathed in 
Tyrode solution and was exposed to 30/xM noradrenaline, 3mM acetylcholine 
and 5mM ATP. All three agonists caused a phasic contraction which only 
relaxed when the agonist was withdrawn. This indicates that the adreno-, 
muscarinic and purino- receptors are functional in the intact muscle bathed in 
Tyrode solution. The factor inhibiting the muscarinic response after 
alpha-toxin-treatment, therefore, must be connected with either the 
permeabilization technique or the composition of the mock intracellular solution.
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30/l/M Noradrenaline
3mM Acetylcholine
120mM K, 40mM Na, 5mM ATP, O.OfyM Ca 
120mM K, 40mM Na, 5mM ATP, 63pM Ca
1.5 n
co'toc
P
0.0 -1 X.
2 mins
Figure 4.1 shows the response of alpha-toxin permeabilized rat anococcygeus 
muscle to 30/xM noradrenaline (hatched bar) and 3mM acetylcholine (heavily 
stippled bar). The bathing solution was changed from one containing 63/xM 
calcium to one of 0.8/iM. This is indicated by the change in the stipple pattern 
of the larger of the bars beneath the two traces.
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Figure 4.2 shows contractions produced by intact rat anococcygeus muscle to 
30/iM noradrenaline (hatched bar), 3mM acetylcholine (heavily stippled bar) and 
5mM ATP (lightly stippled bar), each in Tyrode solution.
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To examine this, Tyrode (with added ATP) was replaced by normal mock 
intracellular bathing medium in an intact strip of anococcygeus muscle. This 
caused a transient contraction (Figure 4.3). Application of NA, but not of ACh 
caused a transient contraction. Figure 4.4 shows that, when the bathing medium 
around the muscle was changed from Tyrode to a mock intracellular solution 
with no added ATP or CrP (40mM NaCl has been added to prevent changes 
in ionic strength) that the muscles contracted transiently and were responsive to 
noradrenaline, acetylcholine and ATP. This inhibitory effect of ATP cannot be 
reversed by adding 1/iM alpha-beta methylene ATP. Alpha-beta-methylene ATP 
is a non-hydrolysable analogue of ATP. It works by desensitising P ^  receptors 
(Kasakoz & Burnstock, 1983; Delebro et al, 1985). The effect of ATP does, 
however, prove to be a problem. ATP has to be present in the mock 
intracellular solutions to fuel contraction. The results from Chapter 3 (Figure 
3.2) show that removing ATP from the solutions causes the muscle to go into 
rigor. During any further analysis of findings, made using this preparation this 
inhibitory effect of ATP on the muscarinic response must be kept in mind.
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Figure 4.3 shows contractions of intact rat anococcygeus muscle induced by 
30/iM noradrenaline (hatched bar) and 3mM acetylcholine (heavily stippled bar) 
in a mock intracellular solution with 5mM ATP. Prior to the solution change 
indicated by the lightly stippled bar underneath the tension record the muscle 
had been bathed in Tyrode solution with added ATP.
89
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^  I 120mM K, 40mM Na, 0 ATP, 0.08/l/M Ca
1.5 n
0.0 J
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Figure 4.4 shows contractions of intact rat anococcygeus muscle induced by 
30/xM noradrenaline (hatched bar), 3mM acetylcholine (heavily stippled bar) and 
5mM ATP (lightly stippled bar) in a mock intracellular solution which does not 
contain ATP. This is indicated by the open bar underneath the tension record. 
Prior to the solution change indicated the muscle had been bathed in Tyrode 
solution.
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THE EFFECT OF GTP ON NORADRENALINE-ACTIVATED CONTRACTIONS
All the muscles used were stabilized by repetitively evoking contractions 
with lOmM caffeine. The SR was allowed to accumulate calcium for 10 minutes 
in a solution with a fixed [Ca2+] below the threshold for contraction. During 
each calcium load and release cycle caffeine (lOmM) was applied for 2 minutes, 
washed out and the muscle allowed to accumulate calcium for 1 0  minutes and 
so on. This was continued until the muscle produced reproducible contractions 
in response to caffeine. Once this had been achieved 30/xM noradrenaline was 
applied which produced a transient contraction in rat anococcygeus (Figure 4.5) 
and guinea pig portal vein (Figure 4.7). Noradrenaline is thought to produce 
its response by stimulating phospholipase C to produce Ins(l,4,5)P3  and DG. 
Ins(l,4,5)Pj then releases calcium from the intracellular store (Streb et al. 1983) 
which causes the muscle to contract. Ins(l,4,5)Pj is rapidly broken down 
(Berridge and Irvine, 1989) which might explain why the contraction observed 
here is transient.
(a) Rat Anococcygeus
Figure 4.5 consists of two panels showing the effects of GTP on 
noradrenaline-activated force when applied at different times in the experimental 
protocol. Figure 4.5A shows the stabilized contractions in response to caffeine 
followed by a series of transient contractions in response to noradrenaline. The 
amplitude of the noradrenaline-activated contraction declines with time. 
Exposing the muscle to 100/iM GTP causes a contraction itself which on average
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Figure 4.5 shows the effect of 100/xM GTP on the response to noradrenaline in 
permeabilized rat anococcygeus muscle. The application of lOmM caffeine 
(open bar), 30/iM noradrenaline (hatched bar) and 100/iM GTP (filled bar) are 
indicated. Panel A shows the effect of exposing the muscle to GTP after three 
previous contractions in response to noradrenaline. Panel B shows the effect 
of exposing the muscle to GTP after only one response induced by 
noradrenaline.
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was 64% (±14%, n=3) of the first contraction in response to noradrenaline. 
The presence of 100/iM GTP transiently potentiates the next response to 
noradrenaline, but it does not reverse the decline in peak tension. Application 
of 100/iM GTP after the first noradrenaline-activated contraction also causes a 
contraction by itself (Figure 4.5B). This on average was marginally larger than 
the first noradrenaline-activated contraction (114% ± 2 2 , n = 6 ) although not in 
the example shown here. The peak of the next contraction in response to 
noradrenaline had not declined as much as it would have had there been no 
GTP present in the solution. However, the presence of GTP did not stop the 
decline in the amplitude of the contractions evoked by noradrenaline. Removal 
of GTP in both protocols had no obvious effect on the response. The 
contractions to noradrenaline in both panels gradually became smaller until 
eventually only a small tonic component was visible. Figure 4.6 shows the 
average noradrenaline-activated contraction expressed as a percentage of the 
first contraction in response to noradrenaline for the two different protocols just 
described for rat anococcygeus. This figure shows that GTP (100/xM) does not 
reversibly halt the decline in the amplitude of noradrenaline-activated 
contractions. The peak of the response to noradrenaline, directly after 
application of GTP, was potentiated but only to 67% and 6 8 % of the first 
noradrenaline-activated contraction. This potentiation by GTP appears to be 
independent of what has occurred in the muscle before its addition.
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Figure 4.6 shows the average data for the decline in the amplitude of the 
response induced by noradrenaline in permeabilized rat anococcygeus and how 
this is affected by GTP. Each point has been expressed as a percentage of the 
amplitude of the first noradrenaline-activated contraction. The points represent 
the mean±S.D. (n=3-8).
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(b) Guinea Pig Portal Vein
Figure 4.7 also has two panels which contrast the effects of exposing the 
muscle to GTP at different times in the experimental protocol. Both the 
muscles have been stabilized using repetitive exposures to caffeine. Once the 
muscle had stabilized a series of exposures to noradrenaline were undertaken. 
The amplitude of successive noradrenaline-activated contractions in portal vein 
also decline with time. However, this decline in peak tension in response to 
noradrenaline was slower than in rat anococcygeus. Exposing the muscle to 
100/zM GTP did not in itself cause a contraction. However, the peak of the 
response to noradrenaline was potentiated and this potentiation lasted as long 
as the muscle was exposed to GTP. On removal of GTP the amplitude of the 
noradrenaline-activated contractions declined once again. Panel B shows that 
applying GTP (100/zM) after the first noradrenaline-activated contraction also 
does not cause a contraction, but does potentiate the amplitude of the 
noradrenaline-activated contractions which followed. Again, the size of the 
response to noradrenaline were maintained for the period that the muscle was 
exposed to GTP. On removing GTP peak tension evoked by noradrenaline 
declined. Figure 4.8 shows the mean peak tension in response to noradrenaline 
expressed as a percentage of the peak tension of the first contraction in 
response to noradrenaline for the two different protocols just described. GTP 
(100/iM) potentiated the amplitude of noradrenaline induced contractions to the 
extent that they were greater (148% and 144%) than the first noradrenaline 
induced contraction. This potentiation appears to be
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Figure 4.7 shows the effect of 100/iM GTP on noradrenaline-activated force in 
permeabilized guinea pig portal vein longitudinal muscle. The application of 
lOmM caffeine (open bar), 30/iM noradrenaline (hatched bar) and 100/iM GTP 
(filled bar) are indicated. Panel A shows the effect of exposing the muscle to 
GTP after three previous contractions in response to noradrenaline. Panel B 
shows the effect of exposing the muscle to GTP after only one response induced 
by noradrenaline.
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Figure 4.8 shows the average data for the decline in the amplitude of the 
response induced by noradrenaline in permeabilized guinea pig portal vein 
longitudinal muscle and how this is affected by GTP. Each point has been 
expressed as a percentage of the amplitude of the first contraction induced by 
noradrenaline. The points represent the mean±S.D. (n=3-8).
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independent of the time in the protocol that the muscle was exposed to GTP.
In summary, the amplitude of successive noradrenaline-activated 
contractures in both rat anococcygeus and guinea pig portal vein declines with 
time. The decline is greater, however in rat anococcygeus. The decline can be 
reversed in guinea pig portal vein by exposing it to GTP (100/iM). This is not 
the case in rat anococcygeus where the decline is only transiently arrested by 
GTP. Finally GTP caused a transient contraction in rat anococcygeus, but not 
in guinea pig portal vein.
THE EFFECT OF GTP ON CAFFEINE- AND Ins(I,4,5)P3-ACTIVATED CONTRACTIONS.
Figure 4.9 examines the effect that GTP (100/xM) has on caffeine induced 
contractures in permeabilized rat anococcygeus. The muscle was stabilized by 
evoking repeated contractions with caffeine. The first contraction in the trace 
is representative of these. Noradrenaline, followed by GTP was applied as 
shown. GTP caused a transient contraction and the amplitude of the
subsequent contraction in response to noradrenaline was potentiated initially, but 
then declined successively. The amplitude of the response to caffeine, however, 
actually increased with time possibly indicating that there was more calcium 
available for release. This suggests that the amplitude of the noradrenaline 
response does not decay because of inadequate loading of the intracellular store
in the presence of 100/iM GTP.
The decay in the amplitude of the response to noradrenaline could be 
explained if the intracellular store became less sensitive to Ins(l,4,5)Pj in the
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Figure 4.9 shows the effects of 100/xM GTP on the response induced by 
noradrenaline and caffeine in permeabilized rat anococcygeus muscle. The 
application of lOmM caffeine (open bar), 30^M noradrenaline (hatched bar) and 
100/xM GTP (filled bar) are indicated.
presence of GTP. Figure 4.10 has three panels. Panel A shows responses to 
a range of Ins(l,4,5)Pj concentrations by rat anococcygeus. It can be seen that 
the response to Ins(l,4,5)Pj approaches a maximum at a concentration of 
200/xM. Panel B investigates the effect of GTP (100/iM) on the size of the 
Ins(l,4,5)P5-activated contraction. The effect was examined at two different 
concentrations, 50 and 100/iM. The muscle was stabilized by repeated
challenges with caffeine the last of which is shown as the first contraction in 
Panel B. The muscle was then exposed to Ins(l,4,5)P3. After applying GTP 
(100/iM) the muscle was exposed for a second time to each of the two different 
Ins(l,4,5)P3  concentrations. It can be seen that GTP has no effect on the size 
of either response to Ins(l,4,5)P3. Panel C illustrates the amplitude of the 
response to 50/iM Ins(l,4,5)P5  before and after the now familiar decay in the 
amplitude of the response to noradrenaline. The amplitude of the response to 
Ins(l,4,5)P3  was similar before and after the decay in the amplitude of the 
response to noradrenaline. These results. indicate that the decay in the 
amplitude of the response to noradrenaline is not due to a reduced sensitivity 
of the intracellular store to Ins(l,4,5)Pj. It would seem more likely that the 
decay is due to reduced production of Ins(l,4,5)P3  by the agonist.
THE EFFECT OF A HIGHER CONCENTRATION OF GTP ON NORADRENALINE- 
ACTIVATED CONTRACTIONS
One possible explanation for the failure of 100/xM GTP to cause a 
contraction in guinea pig portal vein is that this muscle is less sensitive to GTP 
than rat anococcygeus. Figure 4.11 shows that, in both rat anococcygeus and
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Figure 4.10 shows the effects of noradrenaline and GTP on the contraction 
produced by Ins(l,4,5)P3  in permeabilized rat anococcygeus. The application of 
lOmM caffeine (open bar), 30/xM noradrenaline (hatched bar), 100/xM GTP 
(filled bar) and Ins(l,4,5)P3  (stippled bars) are indicated. Panel A  shows the 
effect of increasing concentrations of Ins(l,4,5)P3  on the tension response. Panel 
B shows the effect of GTP on the response induced by Ins(l,4,5)P5. Panel C 
shows the effect of the decline in the amplitude of the response induced by 
noradrenaline on the amplitude of the response to Ins(l,4,5)P5.
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Figure 4.11 shows the effects of ImM GTP on the response induced by 
noradrenaline and caffeine in permeabilized rat anococcygeus (Panel A) and 
permeabilized guinea pig portal vein (Panel B). The application of lOmM 
caffeine (open bar), 30/xM noradrenaline (hatched bar) and 100/xM GTP (filled 
bar) are indicated.
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guinea pig po rta l vein, 100/iM and ImM G TP had  a similar effect on 
noradrenaline-activated  force. This higher concentration of G TP (ImM) still 
failed to  p rom ote  a contraction in guinea pig po rta l vein or inhibit the decay in 
the  am plitude of the response to  noradrenaline in ra t anococcygeus. The 
contraction  produced  by G TP in the  la tte r tissue averaged 116% ( ± 43% ,n = 3) 
o f the  first contraction in response to  noradrenaline, which is essentially the 
sam e as the  contraction produced  by 100/iM G TP (114%±22%, n = 6 ).
THE EFFECT OF GTP-7 -S ON NORADRENALINE-ACTIVATED CONTRACTIONS
G TP-7-S is a non-hydrolysable analogue of G TP. T he effect o f 100/iM 
GTP-7-S on the  response to  noradrenaline was investigated in perm eabilized ra t 
anococcygeus and guinea pig portal vein. F igure 4.12A shows the effect 
observed in ra t anococcygeus. GTP-7-S was applied  afte r the  now familiar 
decline in th e  am plitude of the  response to  noradrenaline. GTP-7-S (100/iM) 
caused a  large transien t contraction and  blocked all subsequent 
noradrenaline-activated  contractions. This effect of GTP-7-S was not reversible. 
F igure 4.12B shows a typical tension record  obtained  from  guinea pig portal vein 
using the  sam e protocol as described for ra t anococcygeus. GTP-7-S caused a 
transien t contraction and thereafte r the response to  noradrenaline was blocked. 
This effect o f 100/zM GTP-7-S was no t reversible. This experim ent was 
rep ea ted  using 10/iM GTP-7-S in bo th  tissues and similar results w ere obtained 
(data  no t shown). In summary, 10 and 100/iM GTP-7-S alone cause contraction 
in bo th  ra t anococcygeus and guinea pig portal vein. In the  presence of
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Figure 4.12 shows the effects of 100/xM GTP-7 -S on the response induced by 
noradrenaline in permeabilized rat anococcygeus (Panel A) and permeabilized 
guinea pig portal vein (Panel B). The application of lOmM caffeine (open 
bar), 30/xM noradrenaline (hatched bar) and 100/iM GTP-7 -S (filled bar) are 
indicated.
104
GTP-7 -S both muscles proved unresponsive to noradrenaline and this effect was 
not reversible.
THE EFFECT OF GDP-£-S ON NORADRENALINE-ACTIVATED CONTRACTIONS
GDP-0 -S is a non-hydrolysable analogue of GDP. GDP-^-S binds to the 
G-protein and inactivates the protein (Williamson, 1986). Figure 4.13 illustrates 
the effect of GDP-^-S on noradrenaline-activated force in rat anococcygeus and 
guinea pig portal vein. GDP-^-S (100/iM) did not produce a contraction and, 
in rat anococcygeus it did not immediately abolish the noradrenaline-activated 
contractions. However, it slowed the time course of the contraction in response 
to noradrenaline immediately after its application and abolished all subsequent 
responses to noradrenaline. This effect was not reversible. Figure 4.13B shows 
the effect of GDP-yS-S on guinea pig portal vein. GDP-^-S (100/iM) did not 
produce a contraction, but it did inhibit subsequent contractions in response to 
noradrenaline. This effect was at least partially reversible when GDP-£-S was 
removed. In summary, GDP-^-S does not produce a contraction on its own in 
either type of permeabilized muscle. However, it does inhibit further 
contraction to noradrenaline. This is immediate and reversible in guinea pig 
portal vein and after one contraction to noradrenaline in rat anococcygeus. 
The effect of 100/xM GDP-£-S was not reversible in rat anococcygeus and only 
partially in guinea pig portal vein, however, the irreversible effect on 
anococcygeus might be a result of the irreversible decay in the amplitude of the 
response to noradrenaline.
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Figure 4.13 shows the effect of 100/iM GDP-/3 -S on the response to 
noradrenaline in permeabilized rat anococcygeus (Panel A) and permeabilized 
guinea pig portal vein (Panel B). The application of lOmM caffeine (open bar), 
30/xM noradrenaline (hatched bar) and 100/iM GDP-/S-S (filled bar) are 
indicated.
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THE EFFECT OF GTP AND NORADRENALINE ON CALCIUM-ACTIVATED FORCE
The experiments reported so far have investigated the effect of GTP on 
the release of calcium from the intracellular store. This next set of experiments 
examines the effect of GTP and noradrenaline on calcium-activated force. This 
line of investigation was stimulated by reports in the literature that GTP and 
agonists which activate the Ptdlns cycle increase calcium sensitivity of the 
contractile proteins (Nishimura et al,1988; Kitazawa et al, 1989; Fujiwara et al, 
1989; Kobayashi et al, 1989). Figure 4.14A shows a cumulative concentration 
response curve to calcium in permeabilized rat anococcygeus. The [Ca2+] was 
raised in the bathing solution as indicated by the steps underneath the tension 
record. Tension was allowed to reach a plateau before the next concentration 
of calcium was added. Figure 4.14B shows the best fit curves for results from 
three different experiments in permeabilized rat anococcygeus and guinea pig 
portal vein. Each curve was expressed as a percentage of its own maximum. 
It can be seen that the two permeabilized muscle types have a similar 
calcium-sensitivity. However, rat anococcygeus is more sensitive to calcium than 
portal vein. The mean maximal calcium-activated force produced by muscle 
strips (approximately 100/iM in diameter) from rat anococcygeus muscle was 
1.16mN (±0.35, n=5), compared with only 0.25mN (±0.14, n = 8 ) in guinea pig 
portal vein.
Figure 4.15A  and B shows the effect of noradrenaline and GTP on rat 
anococcygeus and guinea pig portal vein respectively whilst the muscle was 
calcium-activated. The muscles are assumed to be calcium-activated when they
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Figure 4.14 shows the sensitivity of toxin-penneabilized smooth muscle to 
calcium in the presence of lOmM EGTA. Panel A  shows a tension record from 
rat anococcygeus muscle. The [Ca2+] was raised in steps as indicated below 
the tension record. Panel B shows a graph of lo g ^C a2*] against normalised 
tension for both permeabilized rat anococcygeus muscle and guinea pig portal 
vein longitudinal muscle. The data plotted are the steady state tensions from 
three experiments carried out on each preparation. The solid line represents 
the best fit curve of the following form of the Hill equation:
T/Tmax = (K,„ x [Ca2+])" /  [1 + (K„ x [Ca2 +])T|
Where T/Tmax is a fraction of maximal calcium-activated force (Tmax); is 
the apparent affinity constant of the myofilaments for calcium. For guinea pig 
portal vein data, n=2.0 and =  104*3. For rat anococcygeus data, n=1.5 and
K, = io“.
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contract when [Ca2+] is raised in the bathing medium and relax when it is 
lowered. The effect of noradrenaline and GTP were examined at three different 
[Ca2+] concentrations: (1) 0.08/xM - a concentration just below the threshold for 
tension; (2) 0.3/xM - a concentration which produces about half maximal 
calcium-activated force in rat anococcygeus and (3) 100/iM - a concentration 
which produces maximal calcium-activated force (Tmax). Each panel shows a 
typical tension record from an experiment performed in a different muscle for 
each [Ca2+]. Each muscle was exposed to the [Ca2+] and allowed to equilibrate 
to it before noradrenaline or GTP were applied.
Figure 4.15A shows that, at the two [Ca2+] which produce tension (0.3 and 
100/zM), noradrenaline increases calcium-activated force. Tension was observed 
to fall when the agonist was removed. GTP (100/zM) also caused an increase 
in calcium-activated force at the two concentrations which produced tension. 
Noradrenaline in the presence of 100/iM GTP produces only a further small 
increase in calcium-activated force.
Figure 4.15B shows that in permeabilized guinea pig portal vein exposure 
to noradrenaline also causes an increase in calcium-activated force. Initially this 
is at all three [Ca2+] but, after the first application of noradrenaline increases 
in calcium-activated force were observed only at the [Ca2+] which produced 
significant tension. GTP (100/iM) causes only a small increase in 
calcium-activated force in comparison to the effect of noradrenaline. 
Subsequent noradrenaline produced large effects on calcium-activated force in 
addition to the effect that GTP has on calcium-activated force.
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Figure 4.15 shows the effects of GTP and noradrenaline on calcium-activated 
force in toxin-permeabilized rat anococcygeus muscle (Panel A) and guinea pig 
portal vein longitudinal muscle (Panel B). The application of 30/jM 
noradrenaline (hatched bar) and 100/tM GTP (filled bar). The [Ca2+] that each 
muscle was equilibrated to is indicated at the side of the experimental tension 
record.
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In summary, noradrenaline increases calcium-activated force reproducibly 
at two of the [Ca2+] tested in both types of permeabilized muscle. These were 
the two [Ca2+] which produced calcium-activated force (0.3 and 100/iM). The 
effect of 100/iM GTP on calcium-activated force was greater in rat anococcygeus 
and the contractions produced by noradrenaline in the presence of GTP were 
greater in guinea pig portal vein. Noradrenaline increased Tmax in both muscle 
types. GTP, however, only increased Tmax in rat anococcygeus.
THE EFFECT OF NORADRENALINE AND GTP-7 -S ON CALCIUM-ACTIVATED FORCE 
T h e  effect o f GTP-7-S (a non-hydrolysable analogue of G TP) on 
calcium -activated force was exam ined a t one calcium level (0.3/iM). GTP-7-S 
binds to  and there fo re  activates G -proteins in com petition with G TP. However, 
because GTP-7-S cannot be  b roken down by the inheren t G T Pase activity of the 
G -pro te in  it activates the p ro te in  for as long as it rem ains bound. Figure 4.16A 
shows th a t no radrenaline repetitively increases calcium -activated force in rat 
anococcygeus. T he calcium -activated tension, shown in the  tension traces, 
p roduced  by bo th  muscles was no t in this instance, m aintained throughout the 
experim ent. This phenom enon was tissue dependent. T he  direction of the 
effect o f NA and  GTP-7-S was always in the sam e direction throughout the 
experim ent. GTP-7-S (100/iM) also increases calcium -activated force. 
N oradrenaline  in the  presence o f GTP-7-S can fu rther increases 
calcium -activated force only by a  small am ount. F igure 4.16B shows essentially 
th e  sam e effect in guinea pig portal vein.
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Figure 4.16 shows the effects of GTP-7 -S and noradrenaline on calcium-activated 
force in toxin-permeabilized rat anococcygeus muscle (Panel A) and guinea pig 
portal vein longitudinal muscle (Panel B). The application of 30/iM 
noradrenaline (hatched bar) and 100/iM GTP-7 -S (filled bar) are indicated. 
[Ca2+] was raised at the time indicated by the arrow underneath the tension 
record and was kept at this level throughout the experiment.
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In summary, GTP-7-S appears to increase calcium-activated force to such 
a extent that there is little further scope to increase the effect by noradrenaline. 
This is the case for both types of permeabilized smooth muscle.
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DISCUSSION
GTP has very different effects on both noradrenaline- and 
calcium-activated force in the two different types of smooth muscle examined: 
rat anococcygeus and guinea pig portal vein longitudinal smooth muscle. These 
differences were:
( 1 ) a different time course of decline in the amplitude of the responses to 
noradrenaline; furthermore the decline in the response to noradrenaline was 
reversed in guinea pig portal vein, but not rat anococcygeus;
(2 ) rat anococcygeus, but not guinea pig portal vein contracted when exposed 
to GTP;
(3) the decline in the amplitude of the response to noradrenaline was greater 
in rat anococcygeus than guinea pig portal vein;
(4) GDP-£-S immediately inhibited the response to noradrenaline in guinea pig 
portal vein, whereas rat anococcygeus was able to contract once more in 
response to noradrenaline and guinea pig portal vein recovered, but rat 
anococcygeus did not;
(5) GTP had a greater effect on calcium-activated force in rat anococcygeus 
than noradrenaline, whereas in guinea pig portal vein the opposite was the case. 
Possible reasons for these differences will be discussed below.
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POSSIBLE MECHANISMS FOR THE Decline IN THE AMPLITUDE OF THE RESPONSE 
TO NORADRENALINE
From the experiments that have been undertaken in this study it is known 
that the decline in the amplitude of the repeated contractions in response to 
noradrenaline is not due to a reduced calcium content of the intracellular store 
(Figure 4.9) or a reduced sensitivity of the muscle to Ins(l,4,5)Pj (Figure 4.10). 
It is also not likely to be due to a decreased calcium-sensitivity of the contractile 
proteins, because the responses induced by caffeine and Ins(l,4,5)Pj are not 
reduced upon successive exposures. The reduction in the size of the response 
to noradrenaline could be explained if the amount of Ins(l,4,5)Pj being released 
at each challenge of noradrenaline decreased. The amount of calcium being 
released in response to noradrenaline through Ins(l,4,5)Pj would thereafter also 
be decreased. The amount of Ins(l,4,5)P5  would be reduced if (a) the amount 
of PtdIns(4,5)P2  in the membrane was reduced; (b) the supply of GTP was 
reduced; or (c) if the receptor/G-protein response was reduced.
(a) Reduction in PtdIns(4,5)P2: The amount of PtdIns(4,5)P2  would be 
reduced in the membrane if the permeabilized muscle was unable to 
reincorporate inositol into the membrane once it had been released as 
Ins(l,4,5)P5. A possible protocol to test this hypothesis would be to include 
myo-inositol in the bathing medium. This mechanism does not explain, however, 
why the amplitude of the response to noradrenaline declines more quickly in rat 
anococcygeus than in guinea pig portal vein unless the latter contains higher 
reserves of PtdIns(4,5)P2.
(b) Reduced Availability o f GTP: Another explanation for the decline in
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the size of the response to noradrenaline, which is suggested at least for guinea 
pig portal vein, is the loss of intrinsic GTP. In guinea pig portal vein the 
decline was reversed (Figure 4.7) by the inclusion of lOO^M GTP in the bathing 
medium suggesting that it was the lack of this substance which was causing the 
decline. There is also a similar decline once GTP is removed from the solution.
Even in rat anococcygeus, loss of intrinsic GTP might explain its ability 
transiently to reduce the decline (Figure 4.5). However, as GTP does not 
completely reverse the effect, then in rat anococcygeus, something other than 
loss of intrinsic GTP must be responsible for the decline in the amplitude of the 
response induced by noradrenaline.
(c) Reduction in the receptor/G-protein Activation'. The amplitude of the 
response to repeated agonist challenges would decline if the amplitude of the 
receptor/G-protein response was reduced after each agonist exposure. That is 
to say, at each exposure there would be a reduced activation of phospholipase 
C and hence production of Ins(l,4,5)P3. There are reports in the literature 
which suggest that activation of the receptor/G-protein activates PKC (through 
DG) which phosphorylates the G-protein (Katada et al, 1985) and receptor 
(Berridge, 1987; reviewed by Sagi-Eisenberg, 1989). The phosphorylated 
receptor/G-protein has a lower activity and, therefore, produces less Ins(l,4,5)P5  
when it is activated (Baba et al, 1989). Hence, the amplitude of successive 
responses to noradrenaline will decline.
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A POSSIBLE MECHANISM FOR GTP-INDUCED CONTRACTION
A  major difference in the response of the two muscle types was that rat 
anococcygeus contracted when exposed to GTP, but guinea pig portal vein did 
not. The response of guinea pig portal vein was as expected. Most other 
workers using permeabilized smooth muscle preparations have reported that 
GTP on its own does not cause a contraction (Saida et al, 1987), but that it 
potentiates contractions to agonists (Kitazawa et al, 1989). For fuller review see 
the introduction.
Experiments with rat anococcygeus have already shown that this muscle’s 
response to agonists was affected by the presence of ATP in the bathing 
medium. Figures 4.1 to 4 show that having ATP in the bathing medium blocks 
the muscle’s response to acetylcholine (3mM). ATP is essential to prevent the 
permeabilized muscle from forming rigor crossbridges. Rat anococcygeus 
contracts in response to ATP (Gillespie, 1972; Burnstock, Cock & Crow, 1978). 
P^-purinoreceptors cause contraction in smooth muscle (Burnstock & Warland, 
1987). These can be antagonised by ANAPP5  (Hogaboom et al, 1980) or 
desensitised by alpha-beta-methylene ATP (Kasakov & Burnstock, 1983; Delbro 
et al, 1985).
Alpha-toxin permeabilization preserves functional receptors (Nishimura et 
al, 1988; Kitazawa et al, 1989) so it has to be assumed that the purinoreceptors 
remain operational. In the continuous presence of ATP (5mM) the 
purinoreceptors and the associated G-protein will be chronically activated. 
Hence, when GTP is present it will provide ’substrate’ for the activated
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receptor/G-protein which can then cause a contraction by activating 
phospholipase C and producing Ins(l,4,5)P3  and DG. Exogenous ATP does not 
appear to be a significant problem in guinea pig portal vein. This tissue does 
have purinoreceptors, but they seem to have different characteristics from those 
in rat anococcygeus.
It has proved to be very difficult to test this hypothesis. This is mainly due 
to the fact that there are no good antagonists for purinoreceptor responses and 
alpha-beta-methylene ATP (a desensitising agonist) had no effect on the 
response. It functions by chronically activating the receptor and eventually 
desensitizing it to ATP. As described in the results section, a side effect of the 
presence of ATP appears to be the inhibition of the response to ACh. In a 
number of experiments alpha-beta methylene ATP was added to the muscle for 
thirty minutes before the muscle was permeabilized, during the permeabilization 
procedure and thereafter. Despite this alpha-beta-methylene ATP was not able 
to block the effect that ATP has on the response to acetylcholine. This might 
be a consequence of the permeabilization or ATP might be having its effect via 
another purinoreceptor.
Evidence for the chronic activation of G-proteins in rat anococcygeus 
muscle comes from the results obtained with GTP-7 -S which activates G-proteins 
without an agonist present. The responses of permeabilized rat anococcygeus 
and guinea pig portal vein to this compound are identical and similar to those 
produced by GTP seen in rat anococcygeus.
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POSSIBLE REASONS FOR THE GREATER DECLINE IN THE AMPLITUDE OF THE 
RESPONSE TO NORADRENALINE IN RAT ANOCOCCYGEUS.
The possible causes of the fall in the size of successive 
noradrenaline-activated contractures has already been discussed. The most 
plausible explanation is that the decline is due to desensitisation of the 
receptor/G-protein as a result of phosphorylation of the proteins by PKC. 
There are several explanations for the faster decline in the size of the response 
to noradrenaline in rat anococcygeus compared with guinea pig portal vein: (a) 
a lack of enzymes which cause the phosphorylation in guinea pig portal vein;
(b) a lack of enzymes which cause dephosphorylation in rat anococcygeus; (c) 
the activation of purinoreceptors by ATP might accelerate the decline in rat 
anococcygeus, but not in guinea pig portal vein.
(a) Possible lack o f enzymes which cause phosphorylation: Perhaps guinea 
pig portal vein lacks the enzymes which phosphorylate the receptor/G-protein 
system, but these enzymes are present in rat anococcygeus. Thus the decline 
observed in guinea pig portal vein could then be explained by the loss of 
intrinsic GTP alone. This could be partially tested by using a phorbol ester to 
activate PKC and then examining the effect on the response to noradrenaline. 
The problem with this experiment would be that activating PKC in this manner 
not only phosphorylates the receptor/G-protein, but also the contractile proteins, 
making them more calcium sensitive. Therefore, a more specific agent to 
phosphorylate the receptor/G-protein would be required.
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(b) Possible lack o f enzymes which cause dephosphorylation: If rat
anococcygeus lacked, or had a reduced amount of, functioning enzymes which 
caused dephosphorylation, this would also explain the faster decline in the size 
of the response to noradrenaline in rat anococcygeus compared with guinea pig 
portal vein. One possible way to examine this would be to study the decline in 
the presence of okadaic acid, a known blocker of phosphatases (Somlyo et al, 
1990). This might make the dephosphorylation abilities of the two muscles more 
comparable.
(c) Possible effect o f ATP on the level o f phosphorylation: It has already 
been demonstrated that ATP blocks the response to acetylcholine in rat 
anococcygeus. ATP might chronically activate a sub-population of G-proteins 
to enable GTP alone to produce a contraction. The activation of this 
sub-population of G-proteins might increase basal levels, and subsequently the 
overall level, of phosphorylation when an agonist is applied. This would imply, 
however, that the size of the first contraction in response to noradrenaline would 
be smaller the longer the time that the muscle had spent in the ATP-containing 
solution. This did not appear to be the case, although it was not systematically 
studied. Another possibility is that this chronic activation with ATP inhibits the 
enzymes which normally dephosphorylate the receptor and G-protein.
A POSSIBLE REASON FOR THE EFFECT OF GDP-^-S
Inhibition of an agonist response by GDP-/J-S is usually taken as evidence
that the agonist mediates its response through a G-protein. Normally this effect
is immediate and reversible, as was the case for guinea pig portal vein. The
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effect of GDP-^-S on rat anococcygeus, however, was delayed until the muscle 
had been activated once more by noradrenaline and was not reversible. There 
is no clear explanation for this effect. However, its basis might lie in the state 
of the G-protein when GDP-6 -S was added.
The effect of GDP-6 -S is not reversible in rat anococcygeus, but it is in 
guinea pig portal vein. A possible explanation for this can also be suggested 
within the frame of the hypothesis. Activation of receptors in both muscle types 
causes phosphorylation of the receptor/G-protein and so causes the amplitude 
of successive contractions induced by noradrenaline to decline. Rat 
anococcygeus appears to have higher rate of phosphorylation which might be 
related to the chronic activation of the purinoreceptors and associated G-protein. 
The chronic activation induced by ATP will continue in rat anococcygeus in the 
presence of GDP-/3-S until all the bound GTP has been replaced by GDP-/9 -S. 
Hence, phosphorylation of the receptor/G-protein system will also continue 
making it less likely that this muscle type will recover its ability to respond to 
noradrenaline when GDP-^-s is removed.
In summary, the basic differences between the two preparations can be 
explained if their enzymes have different phosphoiylation/dephosphorylation 
activities. Rat anococcygeus’s enzymes would appear to have an increased 
phosphorylation activity or a decreased dephosphorylation activity compared with 
guinea pig portal vein. This imbalance might be related to the chronic 
purinoreceptor stimulation. Such chronic stimulation might also explain why the 
muscle contracts in response to GTP.
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A POSSIBLE EXPLANATION FOR GTP’s GREATER EFFECT ON CALCIUM-ACTIVATED 
FORCE IN RAT ANOCOCCYGEUS
The previous section has investigated GTP’s effect on calcium release. 
However, the potentiation of noradrenaline-induced force by GTP could be 
explained by an increase in the sensitivity of the contractile proteins to calcium. 
The results from both rat anococcygeus and guinea pig portal vein show that, 
at the [Ca2+] used in the experiments to examine GTP’s effect on calcium 
release (a [Ca2+] below threshold for tension), noradrenaline and GTP had no 
significant effect on calcium-activated force. However, at the [Ca2+] s which did 
cause contraction, noradrenaline and GTP did increase calcium sensitivity and 
Tmax in both tissues. However, in relative terms the two tissues were affected 
differently. Calcium-activated force was affected more by noradrenaline in 
guinea pig portal vein but more by GTP in rat anococcygeus. The result found 
in guinea pig portal vein was consistent with the published literature (see 
introduction). The increase in Tmax has been reported only by one other group 
(Kitazawa et al, 1989). Phosphorylation of the contractile proteins by PKC has 
been suggested as the cause of the increased calcium-activated force. Fujiwara 
et al (1989) have reported that, in saponin permeabilized mesenteric arteiy, 
there is increased phosphorylation in the presence of GTP-7 -S. However, the 
authors were not certain that all of the effect could be explained by activation 
of PKC because TP A (an activator of PKC) has been reported to decrease 
Tmax (Itoh et al, 198% Itoh et a\; 1988 and Fujiwara et al, 1988) whereas in 
their hands GTP-7 -S had no effect on maximum calcium sensitivity. Kobayashi 
et al (1989) have proposed another method to account for the increase in
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maximum calcium-activated force, suggesting that phosphatases acting on the 
myosin light chain are inhibited by GTP-7 -S.
Guinea pig portal vein can be made to react in a similar manner to rat 
anococcygeus by adding GTP-7-S instead of GTP (Figure 4.16). As has already 
been discussed, GTP-7-S is a non-hydrolysable analogue of GTP, which 
chronically activates the G-protein. This result suggests that, in rat 
anococcygeus, a sub-population of G-proteins are chronically activated so that 
GTP acts in a similar manner to GTP-7 -S.
In conclusion, the two tissues, rat anococcygeus and guinea pig portal vein, 
respond very differently to GTP. This difference includes their response to GTP 
with respect to both calcium release and calcium-activated force. In guinea pig 
portal vein GTP does not in itself release calcium, but does potentiate 
noradrenaline-activated calcium release. In this preparation, GTP has only a 
small effect on calcium-activated force in comparison with the effect of 
noradrenaline on calcium-activated force. The results obtained with guinea pig 
portal vein are consistent with current understanding of the involvement of 
G-proteins in the agonist transduction system in smooth muscle. Rat 
anococcygeus, on the other hand, reacted in a novel manner to GTP with 
respect to both calcium release and calcium-activated force. GTP itself caused 
a contraction and only transiently potentiated noradrenaline-activated force. It 
also had a greater effect on calcium-activated force than noradrenaline. Both 
muscle types could be made to react in the same manner by using GTP-7-S 
instead of GTP; that is, both contracted in response to GTP-7-S itself and
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GTP-7 -S had a greater effect on calcium-activated force than noradrenaline. 
This response is similar to the way GTP affects calcium release and 
calcium-activated force in rat anococcygeus. This would indicate that
permeabilized rat anococcygeus muscle has a population of chronically activated 
G-proteins in the presence of ATP which affects its response to GTP.
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CHAPTER 5
THE EFFECT OF LITHIUM ON AGONIST RESPONSES 
IN INTACT AND ALPHA-TOXIN PERMEABILIZED 
SMOOTH MUSCLE FROM RAT ANOCOCCYGEUS.
INTRODUCTION
A. INOSITOL PHOSPHATES
It is over 35 years since Hokin and Hokin (1953) discovered 
receptor-activated metabolism of inositol lipids. In the following 15-20 years 
they described most of its key characteristics. However, despite their intense 
work on this system they were unable to assign a biological function to this 
widespread biochemical response of cells to stimulation. Michell in 1975 
reported that after surveying a large number of tissues showing the 
phosphatidylinositol (Ptdlns) response, he noted that:
( 1 ) the stimulus response mechanism required extracellular calcium, and rises in 
intracellular [Ca2+] occurred on agonist stimulation;
2) the Ptdlns effect was independent or only partially dependent on extracellular 
[Ca2+] in many tissues; and
(3 ) in some tissues, calcium ionophores stimulated the physiological response, 
but not Ptdlns breakdown.
These observations indicated that Ptdlns is a prerequisite to [Ca2+] elevation in 
some cells and led to the hypothesis that Ptdlns synthesis caused the opening 
of calcium-gates in the membrane. Further support was given to this hypothesis 
by Berridge and Fain (1979) who found that stimulation with 5-HT, in blowfly 
salivary gland, caused Ptdlns loss and increased exchange of calcium. At around 
the same time as this Abdel-Latif, Akhatar and Hawthorne (1977) demonstrated 
a rapid breakdown of phosphatidylinositol bisphosphate (PtdIns(4,5)P2) in iris
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smooth muscle after muscarinic or alpha-adrenergic stimulation. Subsequently 
they (Akhatar & Abdel-Latif, 1980) showed that the breakdown was 
accompanied by the formation of 1-InsP, PtdIns(4,5)P2  and inositol triphosphate 
(Ins(l,4,5)Pj). However, these workers did not think that these breakdown 
products had any significance in calcium mobilization because the response was 
partially dependent on [Ca2+] and could be mimicked by a calcium ionophore.
The role of Ins(l,4,5)Pj was not appreciated until 1983, when Streb et al 
reported that it was able to release calcium from an intracellular, 
non-mitochondrial store in isolated rat pancreatic acinar cells. They also 
reported that Ins(l,4,5)Pj released the calcium from the same store as 
acetylcholine. Similar observations have since been noted in smooth muscle 
(Suematsu et al, 1984; Somlyo et al, 1985; Hashimoto et al, 1986). In this tissue 
Ins(l,4,5)P5  acts on the sarcoplasmic reticulum to release calcium which 
subsequently causes contraction.
Much work has been done in trying to understand the Ptdlns cycle. There 
are many breakdown products and branches. These were recently summarised 
by Berridge and Irvine (1989) and their schematic diagram of the cycle is shown 
in Figure 5.1. Receptor activation stimulates a G-protein (Gomperts, 1983) 
which in turn activates phospholipase C which breaks down phosphatidylinositol 
bisphosphate (PtdIns(4,5)P2) and gives two main breakdown products:
(1) diacylglycerol (DG) which remains within the membrane plane; and
(2) inositol triphosphate (Ins(l,4,5)P3) which is released into the cytosol.
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Figure 5.1 A  Summary of known (solid arrows) and suspected (dashed arrows) 
routes of metabolism of compounds containing inositol and phosphate. Myo­
inositol is represented in its chair configuration and all the inositol phosphates 
are numbered in the D-isomer configuration. The enzymes are (1) Ptdlns 
synthetase (CMP-PA; inositol phosphatidyltransferase); (2) PtdIns-3-kinase; (3) 
PtdIns-4-kinase (type II); (4) PtdIns(4)P phosphomonoesterase; (5) PtdIns(4)P- 
5-kinase; (6 ) PtdIns(4,5)P2  phosphomonoesterase; (7) phospholipase C; (8 ) 
diacylglycerol kinase; (9) CMP-PA synthetase; (10) Ins(l,4,5)P3 /Ins(l,3,4,5)P4- 
5-phosphatase; (11) Ins(l,4,5)P3-5 phosphatase; (12) Ins(l:2cyc)P
phosphodiesterase; (13) InsP phosphatase; (14) inositolpolyphosphate-1- 
phosphatase; (15) Ins(l,4,5)Pj-3-kinase; (16) inositolpolyphosphate-4-phosphatase; 
(17) Ins(l,3)P 2 -3-phosphatase; (18) Ins(l,3,4)Pr 6-kinase; (19) Ins(l,3,4,6)P^-5- 
kinase; (20) Ins(l,3,4,5,6)P5 -2-kinase; (21) Ins(3,4,5,6 )P4 -1-kinase; (22) Ins(3)P- 
synthetase. This diagram has been taken from Berridge and Irvine, 1989.
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Another product formed is cyclic inositol triphosphate (cIP3). Its function, 
however, is unclear. The discovery that cyclic inositols are produced in vitro by 
phospholipase C and the demonstration of its biological activity have been well 
documented (Majerus et al, 1986). Cyclic Ins(l,4,5)P5  is a more stable 
compound than Ins(l,4,5)P5  by the virtue of the fact that it is poorly metabolised 
by Ins(l,4,5)Pj phosphatase. It might, therefore, have a role to play in long 
term control of calcium within cells.
Inositol(l,4,5)triphosphate (Ins(l,4,5)P2) appears to bind to a receptor on 
a non-mitochondrial intracellular membrane with the result that a calcium 
channel opens to release calcium into the cytosol (Streb et al, 1983). This has 
been further verified (Ehrlich & Watras, 1988) and it is now proposed that in 
smooth muscle Ins(l,4,5)P2  opens a calcium channel and releases calcium from 
the sarcoplasmic reticulum. There are two routes for metabolism of this 
compound. It can either be dephosphorylated by Ins(l,4,5)P5 -5-phosphatase to 
Ins(l,4)P 2  (Downes, Hawkins & Michell, 1982) or it can be phosphorylated by 
Ins(l,4,5)P3 -3-kinase to inositol tetrakisphosphate (Ins(l,3,4,5)P^) (Batty, 
Nahorski & Irvine,1985). Ins(l,4)P 2  is thought to be inactive, but Ins(l,3,4,5)P^ 
is thought to have a calcium regulating role. This compound, however, has little 
effect on its own. It is thought to act synergistically with Ins(l,4,5)P5. It was 
found in sea urchin eggs that Ins(l,3,4,5)P4  in combination with Ins(2,4,5)P5  
could raise the fertilization envelope. This effect was dependent on both the 
presence of extracellular calcium and on co-injection with a calcium mobilizing 
compound (Ins(2,4,5)P3) (Irvine & Moor, 1986; 1987). Consequently, it was
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proposed that Ins(l,3,4,5)P4  was causing calcium entry after Ins(l,4,5)P5  had 
released the contents of the intracellular store. Morris et al (1987) also reported 
a similar synergism in mouse lacrimal glands. They showed that in single cells, 
neither Ins(l,4,5)Pj nor Ins(l,3,4,5)P^ alone could activate a sustained calcium 
current, whereas together they could. Bradford and Irvine (1987) have since 
demonstrated a specific binding site for Ins(l,3,4,5)P^ on the membrane of 
HL-60 cells which the authors claim is the intracellular receptor for this 
compound, thus giving it more credence as an intracellular second messenger.
I n s (  1 , 3 , 4 , 5)P^ is m e t a b o l i s e d  to  I n s ( l , 3 , 4 ) P 3  by 
Ins(l,4,5)P3 /Ins(l,3,4,5)P^-5-phosphatase. This is also thought to be an inert 
compound physiologically. It can, however, release calcium from the 
intracellular store but it is 30 times less potent than Ins(l,4,5)P5  (Irvine et al,
1986). Its slow rate of formation and removal after termination of the stimulus 
(Berridge & Irvine, 1984) suggest that any possible function is over a 
comparatively long time scale.
Two other inositol phosphates have been recently identified - InsP5  and 
InsP6. However, it is thought that their metabolism occurs through pathways 
which are largely separate from the agonist-sensitive pathway. A pathway of 
synthesis for InsP5  might exist from the agonist-sensitive inositol phosphates 
through the phosphorylation of Ins(l,3,4)Pj to Ins(l,3,4,6)P^ and thence to 
Ins(l,3,4,5,6)P5  (Stephens et al, 1988). However, the main route of synthesis of 
this inositol phosphate is probably through Ins(3,4,5,6)P^. The origin of this 
compound is unknown. It might be formed by phosphorylation of inositol or
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from Ins(l,4,5)P3  (Berridge & Irvine, 1989). InsP6  is probably formed by 
phosphorylation of inositol. Both these compounds exist within cells at quite 
high concentrations (millimolar) (Martin et al, 1986). However, because their 
concentration changes only very slowly after receptor activation (Tilly, 1987) it 
is thought that these compounds do not have an acute second messenger role. 
There is a possibility that they do have a longer-term role in controlling the 
intracellular environment.
Diacylglycerol is the other breakdown product of PtdIns(4,5)P2. It is 
retained within the membrane and functions as a second messenger by activating 
protein kinase C (PKC), but only in the presence of calcium (Nishizuka, 1984). 
Stimulation of protein kinase C by phorbol esters (which are thought to mimic 
the effect of DAG on protein kinase C) has been shown to trigger contraction 
in smooth muscle from various arteries (Rasmussen et al, 1984; Baraban et al, 
1985; Danthuluri & Deth, 1984). Protein kinase C is responsible for 
phosphorylating proteins, although these have- been difficult to identify. It has 
been shown, however, that protein kinase C does phosphorylate myosin isolated 
from smooth muscle (Endo, Naka, & Hidaka, 1982) and there is some evidence 
that, in conjunction with myosin light chain kinase (MLCK), protein kinase C 
might modulate contraction of smooth muscle (Umekawa et al 1985). There 
have also been reports in skinned smooth muscle that protein kinase C increases 
the calcium sensitivity of the contractile proteins (Itoh et al, 1986; 1988; Fujiwara 
et al, 1988). Protein kinase C has also been identified as the kinase which 
phosphorylates active agonist receptors (Llano & Marty, 1987) and G-proteins
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(Sagi-Eisenberg, 1989) causing them to be inactivated. This would give DG a 
role in switching off the agonist-second messenger response. Protein Kinase C 
also appears to have a function in controlling intracellular [Ca2+]. It might 
interact with voltage dependent calcium channels to facilitate calcium entry. 
This has been shown in Aplysia neurones (Deriemer et a/, 1985), Hermissenda 
photoreceptors (Farley & Auerbach, 1986) and rat adrenal medulla (Wakade, 
Malhotra & Wakade, 1986). Protein kinase C might also activate the pumps 
that remove calcium from the cytosol (Drummond, 1985).
The breakdown products of DG might also have cellular effects. 
Diacylglycerol can be converted to arachidonate which can be converted to 
prostaglandins, leukotrienes and thromboxanes. These are collectively called 
eicosanoids and are potent regulators of various physiological responses. 
Arachidonate and its eicosanoids have been shown to increase in concentration 
after agonist-induced increases of inositides. This topic is reviewed by Rana and 
Hokin, (1990).
The primary soluble by-products of PtdIns(4,5)P2  - Ins(l,4,5)P5, 
Ins(l,3,4,5)P^ and Ins(l,3,4)P3  - are subsequently dephosphorylated through a 
number of reactions back to inositol. Diacylglycerol, the insoluble product of 
PtdIns(4,5)P2, is converted by diacylglycerol kinase, to phosphoatidic acid and 
then to  CMP-phosphatidate. This can be combined with inositol by Ptdlns 
synthetase to form Ptdlns. Further phosphorylation of this compound, which is 
now within the membrane plane, reforms the original substrate - PtdIns(4,5)P2.
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B. LITHIUM
Lithium was first reported as a treatment for manic depressive patients in 
1949 by J.F.J. Cade. However, its method of action was unknown. One 
possible explanation was suggested by Allison and Stewart (1971) who reported 
that a single intraperitoneal injection of LiCl (lOmeq/kg) in rats caused a 30% 
reduction in cerebral cortex inositol. They later reported that this could be 
blocked by co-administering atropine or scopolamine with the lithium (Allison 
& Blisner, 1976). In the same year Allison et al (1976) showed that myo-inositol 
1-phosphate (Ins IP) was also elevated in rats treated with lithium and to a 
greater extent than inositol. It was soon discovered that lithium inhibited 
inositol monophosphatases (Naccarato, Ray & Wells, 1974). This was confirmed 
at a more physiological concentration (ImM  as opposed to 250mM) by Hallcher 
and Sherman (1980). Lithium treatment, therefore, prevents the conversion of 
any of the InsP to inositol. Lithium has also been found to inhibit at least one 
o t h e r  p h o s p h a t a s e  in t he  b r e a k d o w n  pa t hway ,  namely  
inositolpolyphosphate-l-phosphatase (Berridge et al, 1983; Storey et al, 1984; 
Burgess et al, 1985). Inhibition of this enzyme prevents the conversion of 
Ins(l,4)P 2  to Ins(4)P and of Ins(l,3,4)P3  to Ins(3,4)P2. Normally there are three 
main routes for the supply of inositol:
(1) recycling of Ptdlns;
(2 ) de novo synthesis from glucose-6 -phosphate; and
(3) the diet.
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The first two of these possible routes are inhibited by lithium. Thus when the 
Ptdlns cycle is repetitively or continually stimulated in the presence of LiCl the 
level of inositol will decrease within the cell and the response to the agonist will, 
therefore, also decrease. It cannot be regained by de novo synthesis because 
this involves the monophosphatases which are blocked by lithium. The only 
means of maintaining inositol is for it to come from the diet. Berridge et al 
(1983) proposed that, because the brain does not have access to dietary inositol, 
this might explain why lithium treatment is selective for the brain in manic 
depressive patients.
There have been reports of lithium affecting other sites in the agonist 
transduction mechanism. Lithium has been reported to decrease the number 
of new agonist receptors incorporated into skeletal muscle membranes (Pestronk 
& Drachman, 1987). However, this process is also influenced by the 
intracellular [Ca2+] and so might be a secondary effect of the inhibition of the 
Ptdlns cycle. Avissar et al (1988) have also-reported that lithium blocks the 
G-proteins involved in activating both the Ptdlns cycle and adenylyl cyclase.
C. PURPOSE OF STUDY
The aim of this study was to examine the effect of chronic lithium 
treatment on different agonist responses in intact rat anococcygeus to try and 
analyse if these agonists were producing their effect via the Ptdlns cycle. The 
effect of lithium was examined on:
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( 1 ) concentration response curves to noradrenaline, phenylephrine, acetylcholine 
and 5-HT;
(2 ) noradrenaline, phenylephrine and acetylcholine responses in low calcium 
Krebs solution (0.1/iM); and
(3) finally the effect of short term application of LiCl on responses to 
noradrenaline-, caffeine- and calcium-activated force was investigated in 
alpha-toxin permeabilized anococcygeus muscle.
As has already been stated, lithium is thought to have its effect on the 
Ptdlns cycle by blocking the enzymes which breakdown Ins(l,4,5)Pj to inositol. 
This, therefore, runs down the available inositol within the cell. To try and 
prevent this effect of lithium, myo-inositol was fed to the rats at the same time 
as they were being injected with lithium. The response to the different agonists 
in these muscles was also examined. The acute effects of lithium and myo­
inositol were also examined in alpha-toxin permeabilized rat anococcygeus 
muscle.
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MATERIALS AND METHODS
A. INTACT MUSCLE
ANIMAL PRETREATMENT
Lithium chloride (6 .8 mmoles/kg) was injected intraperitoneally on a daily 
basis for four consecutive days. Eighteen hours after the final injection the rats 
were sacrificed and the tissue isolated. During the four day course of injections 
the animals were given 0.45% saline ad libitum. The ’LiCl plus myo-inositol’ 
treated group was injected daily, as before. In addition, myo-inositol lOmM was 
administered in the 0.45% saline. This is essentially the same protocol as that 
used by Eglen et al (1987).
EXPERIMENTAL PROCEDURE
The rat anococcygeus muscles were isolated and set up for experimentation
as described in Chapter 2 (intact muscle section). The solutions used are
detailed in Table 2.1 in Chapter 2.
PROTOCOL FOR EXAMINING INTRACELLULAR RELEASE USING LOW CALCIUM 
(0.1/iM) KREBS
In an attempt to examine the intracellular release of calcium the muscle 
was bathed in a low calcium Krebs solution (buffered with EGTA to 
approximately 0.1/xM calcium). This external [Ca2+] is below the level of 
calcium needed to permit calcium entry, hence any contraction produced by the
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agonist is thought to be due to release of intracellular calcium. The following 
protocol has been devised to examine this release which has been called the 
intracellular component (ITC). Step 1  is proposed to allow the intracellular 
store to load; if this step is missed out then no contraction can be induced. 
Step 2 lowers the extracellular [Ca2+] to 0.1/xM. Step 3 is the agonist challenge 
step and Step 4 lowers the [Ca2+] again and washes out the agonist before the 
store is reloaded.
(1) Wash with 1.25mM calcium Krebs (10 minutes): twice at 0 minutes and 
once at 5 minutes.
(2) Wash with low calcium Krebs (0.1/xM) (10 minutes): twice at 0 minutes, 
once at 3 minutes and once at 9 minutes.
(3) Challenge with agonist in low calcium Krebs (0.1/zM) (5 minutes)
(4) Wash with low calcium Krebs (0.1/xM) (10 minutes): twice at 0 minutes, 
once at 3 minutes, once at 5 minutes and once at 7 minutes.
B. PERMEABILIZED MUSCLE
EXPERIMENTAL PROCEDURE
Strips of rat anococcygeus muscle were isolated and set up for 
experimentation as described in Chapter 2 (Permeabilized Muscle). The muscle 
was permeabilized as described in Chapter 3 (Materials and Methods). The 
solutions used are detailed in Table 2.3. The potassium salt used was potassium 
propionate. Lithium chloride was added from a 1M stock to the solutions to 
obtain a final concentration of lOmM. The effect that this might have on ionic
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strength was examined by looking at the effect of adding lOmM sodium chloride. 
Myo-inositol and sucrose were added as solids to the solutions.
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RESULTS
Figure 5.2A shows a typical example of a concentration response curve 
(CRC) obtained with noradrenaline. All the CRCs reported in this chapter 
were performed in the same manner: the muscle was allowed to equilibrate to 
each new concentration before the next concentration was added in a cumulative 
fashion. The agonist concentration was increased by half logarithmic units. 
Figure 5.2B shows a typical response to a maximal dose of noradrenaline 
(30jxM) in a muscle which has been incubated in low calcium Krebs (0.1/xM). 
The calcium buffer EGTA was used to maintain the [Ca2+] in the solution at 
0.1/xM. This concentration is low enough to prevent entry of extracellular 
calcium playing a significant role in producing a contraction. Thus any 
contraction produced in response to noradrenaline is assumed to be due to 
release of intracellular calcium. This contraction is called the intracellular 
component (ITC). Figure 5.3A shows the mean of six experiments for six repeat 
contractions to noradrenaline in the low calcium Krebs (0.1/xM). It is only after 
the third contraction that the muscle contracts reproducibly. These same six 
muscles were examined to determine whether the left and right ’legs’ of the 
tissues produced comparable sized contractions (Figure 5.3B). Each point is the 
mean of four consecutive contractions. It can be seen that in only one out of 
six cases the paired muscles are significantly different (Student’s t-test). This
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Figure 5.2A. shows a typical cumulative concentration response curve (CRC) in 
response to noradrenaline (NA) in rat anococcygeus. The agonist concentration 
is increased in half logarithmic units. The next concentration of agonist was 
added when the muscle had equilibrated to the previous concentration. Figure 
5.2B. shows a typical effect of 30/iM noradrenaline from rat anococcygeus 
bathed in a low calcium Krebs (0.1/xM) solution (composition is detailed in 
Chapter 2, Table 2.1).
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Figure 5.3A. shows the average size of six consecutive contractions in low 
calcium Krebs (0.1/xM) from six animals and therefore twelve tissues. Figure 
5.3B. shows the average size of the last four contractions shown in Figure 5.3A 
as a comparison of the contraction size in the Left (L) and right (R) ’legs’ of 
the muscle. The results are shown for each of the six animals as the 
mean±S.D. of the four tests. (**p=0.05)
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result is important because, when the lithium experiments were undertaken, one 
’leg’ was examined for LiCl’s effect on the CRC and the other for the effect on 
the ITC.
The magnitude of the ITC was found to be variable. This was especially 
so when the time in low calcium Krebs (0.1/xM) was altered (this is after the 
muscle had been bathed in 1.25mM calcium Krebs for a fixed time to load the 
calcium stores). Figure 5.4 compares within one muscle the effect on the ITC 
of varying the time in low calcium Krebs (0.1/iM) after the stores have been 
allowed to load. Leaving the muscle for 15 minutes dramatically reduces the 
ITC and leaving it for 5 minutes increases its size. However, not only is the size 
increased, but a second component is introduced. The second component can 
be abolished if the muscle is incubated in nifedipine (1/dM). Figure 5.5 shows 
the size of the ITC after 10 minutes in low calcium Krebs (0.1/^M), 5 minutes 
in low calcium Krebs (0.1/jM) and 5 minutes in low calcium Krebs (O.l/^M) in 
the presence of nifedipine (1/jM). In the five, muscles examined, incubation for 
five minutes increased the ITC and introduced an extra component in three of 
the muscles. This extra component was abolished by nifedipine indicating that 
it was due to calcium entry via voltage operated calcium channels (Spedding,
1987). The size of the peak was also reduced making it more like the ITC 
obtained after 10 minutes incubation. It would appear, therefore, that 
incubating in EGTA for 5 minutes is not a long enough time to reduce the 
extracellular [Ca2+] to such a level that the ITC is due only to intracellular
141
Z
E
i —
co 'cn c
CDH
NA (30/j M)
B.
A.
z
ET—
Co
'< /)c
CD
! \ \ \ \ \ \ \ \x v q
Time (5 mins)
Figure 5.4 shows typical examples from one animal of responses to 30/xM NA 
in low calcium Krebs (0.1/iM). The contractions are compared after different 
incubation times in low calcium Krebs (0.1/iM) and hence various times since 
the intracellular store was loaded: (A) 10 minutes; (B) 15 minutes; (C) 5
minutes.
142
E S S ]  NA (30/vM)
B. C.
KSW W l SSWW1
E n
fSWWM 'K S S 3 KSWWM
co
'inc
0I- E S S 3 ' RXxWWN TWXWWi
2
E
co‘wc
CDH 1XWXWM k m \\N S S S S S l
E
co
' COc  J
CDH SSWWM
Time (5 mins)
Figure 5.5 shows the contractile response to NA in low calcium Krebs (0.1/iM) 
in five different muscles. The contractions are compared after different 
incubation times in low calcium Krebs (0.1/xM) and hence various times since 
the intracellular store was loaded: (A) 10 minutes; (B) 5 minutes, and (C) 5
AA
minutes with l^ M nifedipine throughout the loading period.
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release. Hence, for the rest of the experiments examining the ITC the 
incubation time was set at 1 0  minutes.
It has been proposed that lithium blocks the Ptdlns cycle. In an attempt 
to examine this proposal the responses of rat anococcygeus to a variety of 
agonists were examined and compared with those obtained in rats chronically 
treated with LiCl.
EFFECTS OF LITHIUM ON THE CRC
Figure 5.6 shows the effect of chronic treatment with LiCl on: (A)
noradrenaline CRC, (B) phenylephrine CRC, (C) Acetylcholine CRC and (D) 
5-HT CRC. The curves were undertaken in the following order 5-HT, ACh, NA 
and PhE. LiCl treatment appears to significantly suppress the responses to each 
of the agonists. However, the only agonist in which the sensitivity is affected 
is PhE and even in this case there is no significant difference in the PD 2  values 
(Student’s t-test) (Figure 5.7). Sensitivity was examined after the curves had 
been normalised to their own maximum. Only tissues which had reached a 
clearly defined maximum were examined for an effect on sensitivity. Hence 
5-HT CRC’s were not analysed for the effect of LiCl on sensitivity.
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Figure 5.6 shows mean CRCs in response to (A) NA, (B) PhE, (C) ACh and 
(D) 5-HT. The CRCs have been performed in tissues taken from rats which 
have (closed circles) and have not (open circles) been chronically treated with 
LiCl. Details of the LiCl treatment are give in the Materials and Methods of 
this chapter. Results shown are the mean±s.e.m. (n=6-12). Significance was 
tested using an unpaired Student’s t-test. (* p<0.05 **p<0.01).
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Figure 5.7 shows the normalised results from the CRCs to (A) NA, (B) PhE and 
(C) ACh. Only curves from muscles which reached a clearly defined maximum 
were included and each curve was expressed as a percentage of its own 
maximum. Closed circles denote muscles which have been harvested from rats 
which were chronically LiCl treated and the open circles muscles from untreated 
rats. The PD2 values were calculated for the three agonists under each of the 
conditions and were found not to be significantly different. (mean±s.e.m., * 
p<0.05)
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Since LiCl treatment is supposed to cause the run down of inositol in the 
cytosol (Berridge,1983) the effect of administering myo-inositol in the water of 
the rats at the same time as they are being treated with LiCl was examined. 
The rats freely drank the saline with the myo-inositol since the LiCl has a 
natriuretic action. Figure 5.8 shows that co-administering the myo-inositol 
significantly blocks the inhibitory action of LiCl on (A) NA, (B) PhE and (C) 
ACh. The effect was not examined for 5-HT because the contractile response 
proved to be unreliable in all the tissues examined. Co-administering 
myo-inositol at the same time as LiCl did not have any effect on the sensitivity 
of the muscles to the three agonists (Figure 5.9) Myo-inositol appears to 
prevent the effect of LiCl to such an extent that the CRCs are returned towards 
control levels (Figure 5.10). The responses to NA and PhE in the muscles from 
the rats which have been treated with LiCl plus myo-inositol are greater than 
the control, but the increase is not significant. The response induced by ACh 
is comparable to the control. No standard error bars have been shown for the 
ACh CRC because only three muscles were examine.
The manner in which these experiments were carried out imposes 
restrictions on the analysis. That is, these experiments were undertaken as two 
groups: (1) responses to agonists in tissues which have been harvested from 
chronically LiCl-treated animals compared with responses to agonists in control 
tissues and (2) responses to agonists in tissues which have been harvested from 
chronically LiCl-treated animals compared with responses to agonists in tissues 
which have been harvested from chronically LiCl plus myo-inositol treated
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Figure 5.8 shows mean CRC in response to (A) NA, (B) PhE and (C) ACh.
The CRCs have been obtained from anococcygeus muscle taken from rats which
have been chronically treated with LiCl and myo-inositol (open circles) and in
anococcygeus muscle taken from rats which have been chronically treated with
LiCl (closed circles). Details of the LiCl and myo-inositol treatment are give
in the Materials and Methods of this chapter. (mean±s.e.m., n=3-4, * p<0.05)
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Figure 5.9 shows the normalised results from the CRCs obtained with: (A)
NA, (B) PhE and (C) ACh. Only curves from muscles which reached a clearly 
defined maximum were included and each curve was expressed as a percentage 
of its own maximum. Open circles denote muscles harvested form rats which 
were chronically treated with LiCl and myo-inositol and the closed circles 
muscles from LiCl-treated rats. The PD2 values were calculated for the three 
agonists under each of the conditions and were found not to be significantly 
different using a Student’s unpaired t-test. (mean±s.e.m., n=2-4)
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Figure 5.10 shows mean CRC in response to (A) NA, (B) PhE and (C) ACh. 
The CRCs have been undertaken in tissues taken from rats which have (closed 
circles) and have not (open circles) been chronically treated with LiCl and 
myo-inositol. Details of the LiCl and myo-inositol treatment are give in the 
Materials and Methods of this chapter. (mean±s.e.m., n=3-9). Significance was 
tested using an unpaired Student’s t-test. (* p<0.05)
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animals. These two groups of experiments took place separated by several 
months and so strictly speaking should not be cross interpreted. This means, 
therefore, that the response from the control tissues should not be compared 
with the responses from the LiCl plus myo-inositol treated group. It cannot be 
strictly claimed, therefore, that myo-inositol is preventing LiCl from suppressing 
the response to the agonists to such an extent that they are no different from 
the control. It can only be said that myo-inositol is to some extent preventing 
the effect of LiCl. The other problem is that the design of the experiments 
does not allow the analysis of the effect of myo-inositol on its own. Myo-inositol 
is fed to the LiCl treated rats in their drinking water which they take freely 
because they are natriuretic. It is unknown whether control rats would take the 
myo-inositol in their drinking water and it is almost certain that, because they 
would not be natriuretic, probably would not take an equivalent dose of 
myo-inositol.
In summary, anococcygeus muscle from-rats chronically treated with LiCl 
for four days produces CRCs in response to NA, PhE, ACh and 5-HT which are 
significantly depressed in comparison to the responses in tissues from control 
rats. Although the force produced in response to all these agonists is depressed, 
sensitivity to these agonists is unaffected. This depression in the force produced 
by these agonists is prevented to some extent by feeding the rats myo-inositol 
at the same time as they are receiving the injections of LiCl. The extent to 
which the effect of LiCl is prevented cannot be analysed because two important
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controls are missing i.e. CRC’s in response to these agonists in tissues from (1) 
untreated rats and (2) myo-inositol only treated rats.
EFFECTS OF LITHIUM ON THE ITC
Figure 5.11 shows representative ITC contractions in (A) control and (B) 
muscles from rats chronically treated with LiCl. The effect of chronic LiCl 
treatment is to suppress the ITC produced by all three agonists. 5-HT does not 
produce an ITC. Mean observations are shown in Figure 5.12A. LiCl 
significantly reduces the size of the ITC produced by all three agonists. 
Surprisingly however, after treatment with myo-inositol plus LiCl the effect on 
the ITC is not prevented (Figure 5.12B). It is, however slightly increased with 
regard the effect of LiCl alone. This slight increase is enough to cause the 
response (ITC in LiCl plus myo-inositol for NA and PhE) to be no longer 
significantly different from the control ITC (Figure 5.12C). This is most 
probably due to the manner in which these experiments were undertaken as has 
been discussed above. The experiments were performed in two sections: (1) 
controls and LiCl and (2) LiCl and LiCl plus myo-inositol, separated by several 
months. It would appear that the effect of LiCl in the second set of animals is 
different from that in the first. This is only a problem when the animals from 
the two sets are compared. To obtain a better picture of the difference 
between the LiCl plus myo-inositol treated muscles and control muscles these 
experiments should ideally have been done at the same time. The other results 
from within the two sets of experiments are still valid. In summary, LiCl
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Figure 5.11 shows typical contractions evoked by NA (30/xM), PhE (30/iM) and 
ACh (3mM) in low calcium Krebs (0.1/xM) in: (A) anococcygeus from control 
rats and (B) anococcygeus from rats which have been chronically LiCl treated.
154
Figure 5.12 shows the mean ITC for NA (30/iM), PhE (30/iM) and ACh (3mM). 
In (A) the open bars represent the mean ITC of anococcygeus muscles from 
control rats and the filled bar the mean ITC of anococcygeus muscles from rats 
chronically treated with LiCl. (mean±s.e.m., n=6-12, **p<0.05) (B) compares 
the mean ITC from anococcygeus muscles from rats chronically LiCl treated 
(open bars) and rats chronically LiCl and myo-inositol treated (filled bar). 
(mean±s.e.m., n=4) (C) compares the mean ITC from anococcygeus muscles 
from control rats (open bars) and rats chronically LiCl and myo-inositol treated 
(filled bar). (mean±s.e.m., n=4-6, **<0.5)
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treatment reduces the ITC to NA, PhE, and ACh and this effect could not be 
shown to be prevented by myo-inositol. However, LiCl reduces the maintained 
response to these agonists and this effect is prevented to some extent by 
myo-inositol.
THE EFFECTS OF LITHIUM ON ALPIIA-TOXIN PERMEABILIZED MUSCLE
One explanation of the effect of LiCl alone on the ITC and CRC might 
be that the intracellular store has been depleted or is not loading to the same 
extent. To examine this idea responses evoked by caffeine were examined in 
muscle which had been permeabilized with alpha-toxin. Caffeine releases 
calcium from the sarcoplasmic reticulum (Weber & Herz, 1968) as does 
Ins(l,4,5)P5 (Streb et al, 1983). It has been shown in the previous chapter that 
if caffeine is applied at regular intervals its addition causes contractions of equal 
size and this might be used as an indication of the amount of calcium available 
for release in the sarcoplasmic reticulum. To .examine the effect of LiCl on the 
size of the releasable pool of calcium, four repeat contractions 10 minutes apart 
were induced in normal ’0.2 Relaxing solution’ (two are shown in the diagram), 
four were induced in ’0.2 Relaxing’ with lOmM NaCl (to examine the effect of 
increased ionic strength) and four were induced in ’0.2 Relaxing’ solution with 
lOmM added LiCl. NaCl (lOmM) inhibits the contractions evoked by caffeine, 
but not immediately (Figure 5.13). LiCl or NaCl were added at the same time 
as the caffeine to try to discern whether the reduction in the size of the
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Figure 5.13 shows a typical experimental trace of contractions evoked by caffeine 
(lOmM) in alpha-toxin permeabilized rat anococcygeus muscle. The open bars 
below the trace denote exposure time to caffeine. lOmM NaCl was applied to 
the solution at the time indicated by the solid bar. This was exchanged for 
lOmM LiCl at the time indicated by the stippled bar.
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contraction in response to caffeine was due to a depression of calcium sensitivity 
or due to a reduction in the amount of calcium within the store. If, when the 
compound is added at the same time as caffeine, there is a reduction in the size 
of the contraction then this is most likely to be due to a decrease in sensitivity. 
If, however, the effect does not occur until the next contraction then this 
indicates that the loading of the store has been affected. Since NaCl did not 
immediately inhibit the contraction in response to caffeine then it is probable 
that it is having its effect on the ability of the store to load with calcium. LiCl 
produced a further reduction in size of the contraction in response to caffeine. 
This inhibition is immediate and so is most likely to be due to a decrease in 
the calcium sensitivity of the contractile proteins. The size of the contraction 
does increase slightly indicating that the store is able to load more in the 
presence of LiCl. This possible effect on calcium-sensitivity was examined in 
half maximally and maximally calcium-activated muscle. The results in figure 
5.14A show that NaCl depresses the contraction produced at 0.3/iM and 100/iM 
[Ca2+]. LiCl (lOmM) causes a further depression in calcium-activated force. 
The depressive effect is greater at 0.3/iM calcium than 100/iM calcium which 
indicates that lOmM LiCl is depressing calcium sensitivity of the myofilaments. 
This effect of LiCl is concentration dependent (Figure 5.14B) and is fully 
reversible.
As has been discussed in Chapter 3, one of the advantages of the 
alpha-toxin-treated preparation is that it retains functional membrane-bound
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Figure 5.14A shows the effect of lOmM NaCl (open bar) and lOmM LiCl 
(stippled bar) on calcium-activated force in alpha toxin permeabilized rat 
anococcygeus muscle. The muscle was exposed to the [Ca2+] indicated by the 
’stepped’ line. Panel B shows the effect of increasing concentrations of LiCl 
on calcium activated force. The [Ca2+] that the muscle was exposed to is 
indicated by the lines under the trace and the LiCl concentration is indicated by 
the bars. The solutions used in these experiments comprised ratios of ’10 
Activating’ and ’10 Relaxing’ (their composition is detailed in Chapter 2, Table
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receptors. However, some of the disadvantages of this technique for use in this 
preparation have also been discussed in Chapter 4. The size of the response 
to repeated NA challenges declines and this cannot be readily restored. The 
response to ACh is also lost in these muscles. Therefore, only the response to 
NA was examined in alpha-toxin permeabilized muscle. Since the amplitude of 
the response to NA declines with time in alpha-toxin permeabilized muscle the 
effect of lOmM LiCl on the response to NA has had to be compared with the 
response to NA in an untreated preparation. The effect of LiCl on the 
contraction induced by NA is shown in Figure 5.15. It can be seen that the 
response is veiy small and prolonged, very different from the response to NA 
that was described in Chapter 4. Of the five tissues which were examined in 
this manner two of them did not respond to NA at all. These contractions (in 
presence of lOmM LiCl) induced by NA are only 22.5%±27.4% (x±S.D, n=5) 
of the previous contraction to caffeine (also in LiCl), whereas the other 
contractions (no LiCl) to NA are 73.7%±21.0% (x±S.D., n=13) of the previous 
response to caffeine. These results would indicate that the response to NA is 
significantly reduced in the presence of LiCl and that this reduction cannot be 
completely accounted for by a reduction in calcium-activated force. The results, 
therefore, imply that LiCl interferes with the process linking NA to calcium 
release.
The next step was to examine whether myo-inositol could reverse the 
effect of LiCl in the alpha-toxin permeabilized muscle as it does in the intact
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Figure 5.15. shows the effect of lOmM LiCl (stippled bar) in the ’0.2 relaxing’ 
solution on contractions evoked by caffeine (open bar) and noradrenaline 
(hatched bar).
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muscle. Figure 5.16 shows the effect of lOmM NaCl plus lOmM sucrose (used 
to examine the effect of increased ionic strength and osmolarity) and lOmM 
LiCl plus lOmM myo-inositol on a half maximally and maximally 
calcium-activated muscle. NaCl plus sucrose depresses calcium activation at 
both [Ca2+]’s (0.3^M and 100/xM) and these are further depressed by LiCl and 
myo-inositol. These effects were also fully reversible. Thus myo-inositol did not 
reverse the effect of LiCl on calcium activated force. Myo-inositol also did not 
reverse the effect of LiCl on the contractions induced by caffeine or 
noradrenaline on the two occasions that this experiment was tried (results not 
shown).
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Figure 5.16 shows the effect of lOmM NaCl plus lOmM sucrose (open bar) and 
lOmM LiCl plus lOmM myo-inositol (stippled bar) on calcium-activated force. 
The [Ca2+] in the solutions was changed as indicated by the stepped lines below 
the trace.
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DISCUSSION
This study has shown that LiCl has wide ranging effects on intact and 
alpha-toxin permeabilized rat anococcygeus muscle. A number of explanations 
are possible and some of these are discussed below.
POSSIBLE EFFECT OF LiCl ON RECEPTOR NUMBER
LiCl depressed the size of the contractions to NA, PhE, ACh and 5-HT, 
but it did not appreciably affect the ’sensitivity’ of the muscles to these agonists. 
A  possible factor which could reduce maximum activated force, but not 
sensitivity, would be a non-competitive reduction in the number of receptors in 
the surface membrane. Maximum force would be depressed because there 
would be a reduced number of channels that could be opened by this reduced 
population of receptors. Prestronk and Drachman (1987) have already reported 
that 24-48 hours incubation of cultured cells inT.5mM LiCl reduces the synthesis 
and, therefore, insertion of acetylcholine receptors into the surface membrane. 
This effect can be mimicked by raising the intracellular [Ca2+] and the effect is 
blocked if the cultured cells are bathed in inositol with LiCl. LiCl, therefore, 
might be having its effect directly on the synthesis of the receptors or it might 
be blocking the Ptdlns cycle which might raise intracellular [Ca2+] and this might 
affect receptor synthesis. Intracellular [Ca2+] might be raised if the factors 
postulated to cause calcium release and entry are elevated, for example 
Ins(l,4,5)P5, DG and Ins(l,3,4,5)P,. This possibility could be examined to some
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extent by measuring intracellular [Ca2+] in the presence of LiCl and comparing 
this with the [Ca2+] in LiCl plus myo-inositol treated cells.
POSSIBLE EFFECT OF LiCl ON CALCIUM-ACTIVATED FORCE
Another possible explanation of the reduced maximum response, but not 
reduced sensitivity, in tissues from chronically LiCl treated rats would be if the 
contractile proteins had become less responsive to calcium. There is some 
evidence from this study that, in permeabilized muscle, LiCl did reduce 
calcium-activated force. This has also be reported by Hori et al (1989). In both 
studies LiCl’s effect was reversible. The measurements made in the intact 
muscles were made after the animals had been LiCl treated for 4 days. When 
the measurements were taken the intact muscle was not in contact with LiCl. 
The effect of LiCl on calcium sensitivity in the permeabilized muscle is 
reversible. However, it is not known whether the effects of long term exposure 
to LiCl are reversible. These experiments could not be carried out because the 
integrity of the muscle cannot be retained for the length of time needed. Gow 
and Ellis (1990) have reported that extracellularly applied LiCl takes hours to 
accumulate intracellularly and that the concentration which is achieved is greater 
than the extracellular concentration. LiCl might not be having a direct effect 
on calcium sensitivity, the effect might be supplemented by a reduced 
Ins(l,4,5)P5 and DG production. Indeed the response to NA in the 
permeabilized muscle was reduced by LiCl proportionately more than the effect 
on calcium sensitivity. DG has been reported to raise calcium sensitivity (Itoh
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et al, 1986; 1988; Fujiwara et al, 1989) through its ability to activate PKC. If the 
breakdown pathway for Ins(l,4,5)P5 is blocked by LiCl then the amount of 
inositol within the cell will decrease and so will the amount of PtdIns(4,5)P2 in 
the membrane. This will mean that, when the cycle is stimulated, a reduced 
amount of Ins(l,4,5)P5 and DG will be produced. This could mean that DG will 
have a lesser effect on raising calcium sensitivity which will manifest itself as a 
decrease from control in calcium sensitivity. One way of examining this might 
be to add a phorbol ester or l-oleoyl-2-acetylglycerol (OAG) at the height of the 
contraction to try and further activate PKC. OAG is a synthetic analogue of 
DG and has been shown to work in a similar manner to DG (Nishizuka, 1984). 
Other compounds which might be depressing calcium sensitivity are the 
breakdown products of Ins(l,4,5)P5 which will be accumulating within the cell. 
The effect of these compounds on calcium sensitivity has not been tested most 
probably because they are expensive and have a very short half life. Their 
effect on calcium sensitivity will be easier to examine once stable analogues have 
been produced as has been done for Ins(l,4,5)P5 (Taylor et al, 1989). This 
effect of LiCl on calcium sensitivity assumes that the muscle is apparently 
maximally activated. This could be easily checked by (1) raising the extracellular 
[Ca2+] when the muscle is maximally contracted to examine if the muscle 
contracts more or (2) by measuring the [Ca2+] within the cells. If the [Ca2+] 
rises to the same extent in the LiCl treated cells as the control cells then this 
would indicate, since the LiCl treated muscle is producing less tension, that 
calcium sensitivity is reduced.
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POSSIBLE EFFECT OF LiCl ON CALCIUM ENTRY AND EFFLUX
Calcium influx is less likely to have been affected because maximum 
tension has been reduced and sensitivity of the muscle to the agonists has not 
been affected. If influx had been the limiting factor then it would mean that 
eventually the response would have reached the original maximum. This again 
relies on the assumption that the LiCl treated muscles are maximally activated. 
On the other hand if calcium efflux has been increased this would reduce the 
[Ca2+] which was allowed to accumulate within the muscle cells and so the size 
of the contractions would be reduced. A mechanism linked to Ptdlns to explain 
this is hard to imagine. DG is normally thought to stimulate calcium efflux 
(Drummond, 1985). However, if it is reduced by LiCl then this should decrease 
calcium efflux.
EFFECT OF LiCl AND MYO-INOSITOL ON THE INTRACELLULAR STORE AND FACTORS 
RELEASING THIS STORE
LiCl reduced the ITCs and CRCs induced by the agonists examined. It 
also reduced the contraction induced by NA in the permeabilized muscle and 
the contraction in response to caffeine. Part of this blockade has been shown 
to be an effect on sensitivity in the permeabilized muscle. LiCl per se does not 
seem to affect the size of the intracellular store, although the calcium which can 
be released is affected by increased ionic strength.
The surprising result came when myo-inositol was administered to the rats 
at the same time as they were being LiCl treated. This prevented to some 
extent the effect of LiCl on the CRCs in response to the agonists, but did not
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prevent the effect of LiCl on the ITC in response to the same agonists. 
Myo-inositol also did not prevent the effect of LiCl on calcium sensitivity in the 
permeabilized muscle nor did it reduce the effect of LiCl on the contraction in 
response to caffeine or NA. This might suggest an imbalance between the two 
breakdown products of PtdIns(4,5)P2 breakdown. If it is assumed that the ITC 
is a measure of Ins(l,4,5)P5 activity and the CRC a measure of Ins(l,4,5)P3 and 
DG activity then since the CRC to some extent is restored, but the ITC is not, 
in tissues from rats which have been chronically LiCl and myo-inositol treated, 
it might suggest either that not enough Ins(l,4,5)P3 is being produced to cause 
release of intracellular calcium or that the rate of Ins(l,4,5)Pj production has 
been reduced to a level where the breakdown rate of Ins(l,4,5)Pj is 
approximately the same as the production rate. The latter of these two is the 
more likely considering that: (a) enough DG appears to be produced to cause 
calcium-entry and (b) the two breakdown products are produced at the same 
rate and in the same amounts. The rate of production of DG could be reduced 
without it causing a problem since it has a slower rate of breakdown than 
Ins(l,4,5)P3. On the other hand a slower rate of production of Ins(l,4,5)P5 
could mean that its concentration never reaches a level at which it can have 
an effect because Ins(l,4,5)P3 is broken down so rapidly. Measuring Ins(l,4,5)Pj 
and DG production would be a means for examining this hypothesis.
The effect of myo-inositol might also be a consequence of how these 
experiments were carried out. The missing substrate (inositol) was restored, but 
the breakdown processes of the Ptdlns cycle were still blocked. Perhaps a
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better way to examine whether LiCl’s effect was due to the Ptdlns cycle would 
have been to replace the enzymes which are supposed to have been blocked. 
The intracellular effect of NA could have been to examined more effectively 
in alpha-toxin permeabilized muscle from a rat which had been chronically 
treated with LiCl.
In conclusion, LiCl has a wide range of effects including those of directly 
and indirectly decreasing calcium sensitivity. This affects the responses to NA, 
PhE, ACh and 5-HT. However, only in the case of NA is there evidence that 
LiCl is affecting something more than simply a reduced response of the 
myofilaments to calcium to produce its effect. There is no direct evidence, 
however, that this has anything to do with the Ptdlns cycle as the effect could 
not be prevented using myo-inositol.
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GENERAL CONCLUSIONS
The general aim of this thesis was to obtain a better understanding of the 
transduction mechanism linking membrane bound receptors to tension 
production in smooth muscle. Initial studies were carried out to investigate the 
viability of three different permeabilizing techniques. The experiments 
undertaken provide evidence that all three techniques (saponin, EGTA and a- 
toxin from Staphylococcus aureus) permeabilize the smooth muscle of rat 
anococcygeus. However, each treatment produced preparations with different 
properties and suitability for further experimentation. The basis of the different 
properties may be because each technique forms different sized ’pores’ in the 
surface membrane (Thelestam & Mollby, 1979). Saponin-treatment appears to 
produce the largest pores, and as a result of this the agonist-induced responses 
are absent and there is a rapid decline in the amplitude of maximum calcium- 
activated tension. The reduction in maximal calcium-activated force can only be 
partially prevented by including the protein calmodulin to the bathing solutions 
and using low ionic strength to favour its affinity for calcium. Alpha-toxin- 
treatment produces the next largest ’pores’. Muscles permeabilized by this 
means retain their ability to respond to agonist stimulation and low ionic 
strength is sufficient to prevent the decline in the amplitude of maximum 
calcium-activated force. EGTA-treatment of muscle appears to produce the 
smallest ’pores’ and retains the ability to respond to agonist stimulation, showing 
little decline in the amplitude of maximum calcium-activated force. However, 
EGTA-treated muscle only produces a third of the tension produced by
equivalent saponin- or a-toxin-treated muscles. Overall, a-toxin-treated muscle 
was considered to be the most suitable permeabilization technique and was used 
throughout the rest of the study.
The advantages of a-toxin permeabilization, that is that membrane bound 
receptors were left functional and the muscle internal environment could be 
changed by changing the external bathing solution of the muscle, allowed the 
study of the involvement of G-proteins in the receptor transduction mechanism. 
The effect of GTP and other related compounds on the response induced by 
noradrenaline and calcium activated force were investigated in two different 
smooth muscle types rat anococcygeus, a visceral smooth muscle, and guinea pig 
portal vein, a vascular smooth muscle. These two tissues responded very 
differently to GTP. This difference includes their response to GTP with respect 
to both calcium release and calcium-activated force. In guinea pig portal vein 
GTP does not itself release calcium, but does potentiate noradrenaline-activated 
calcium release. In this preparation, GTP has only a small effect on calcium- 
activated force in comparison with the effect of noradrenaline on calcium 
activated force. The results obtained with guinea pig portal vein are consistent 
with current understanding of the involvement of G-proteins in the agonist 
transduction system in smooth muscle (Kitazawa et al, 1989). Rat anococcygeus, 
on the other hand, reacted in a novel manner to GTP with respect to both 
calcium release and calcium-activated force. GTP itself caused a contraction 
and only transiently potentiated noradrenaline activated force. It also had a 
greater effect on calcium-activated force than noradrenaline. Both muscle types 
could be made to react in the same manner by using GTP-7 -S instead of GTP;
that is, both contracted in response to GTP-7-S itself and GTP-7-S had a greater 
effect on calcium-activated force than noradrenaline. This response is similar 
to the way GTP affects calcium release and calcium-activated force in rat 
anococcygeus. This would indicate that permeabilized rat anococcygeus muscle 
has a population of chronically activated G-proteins which effects its response 
to GTP.
It is now widely accepted that a-adrenoreceptors have their intracellular 
effect via the phosphatidylinositol cycle (Fain & Garcia-Sainz, 1980). A method 
to manipulate this cycle is to block the phosphatases which normally breakdown 
Ins(l,4,5)P5  to inositol using LiCl (Berridge et al, 1983). The effect of LiCl was 
examined in both intact and a-toxin permeabilized rat anococcygeus muscle. 
LiCl has a wide range of effects including directly and indirectly decreasing 
calcium sensitivity. This affects the responses to NA, PhE, ACh and 5-HT. 
However, only in the case of NA is there evidence that LiCl is affecting 
something more than simply a reduced sensitivity of the myofilaments to calcium 
to produce its effect. The evidence, suggests that this effect is via the Ptdlns 
cycle, however, the effect could not be prevented by supplying the muscle with 
myo-inositol.
The majority of this experimental work could be further developed by 
measuring calcium as well as tension. For example it would be interesting to 
see if GTP alone in rat anococcygeus was indeed releasing calcium and if the 
decline in the response to noradrenaline was actually due to decreased release 
of calcium. Another interesting situation in which to measure calcium would be 
in the presence of LiCl when the muscle is stimulated by noradrenaline.
ERRATUM
Page 4, line 10 "via of low resistance" should read "via low resistance".
Page 10, line 3 "Inoue and Isenber, 1990" should read "Inoue and Isenberg, 
1990".
Page 16, line 8 "mitochondiria sequesters" should read "mitochondria sequester". 
Page 16, line 9 "taht" should read "that".
Page 22 "MLCK" and "MLCP" should be inserted after "myosin light chain 
kinase" and "myosin light chain phosphatase" in the figure subscript.
Page 26, line 9 "one" should read "either".
Page 26, line 19 insert "piece" after "Hence the".
Page 39, line 12 insert "(Smith, 1985)" after the equation for ionic strength.
Page 52, line 21 "Figure 4.8" should read "Figure 4.14".
Page 54, line 17 "suppress" should read "depress"
Page 56, line 7 insert after "depolarised muscle." "The transient fall in force in
the intact depolarised muscle is a movement artefact."
Page 58, line 8 "6 or 10 times" should read "6 to 11 times".
Page 65, figure legend "ionic strength 0.1M" should read "ionic strength 0.07M" 
Page 66, figure legend "ionic strength 0.1M" should read "ionic strength 0.07M" 
Page 68, figure legend "ionic strength 0.1M" should read "ionic strength 0.07M" 
Page 77, line 2 "Rojas and Bimbaumer, 1985" should read "Rojas and Bimbauer, 
1985".
Page 86 "0.8^M" should read "0.08/iM".
Page 93, line 1 insert "after the muscle had contracted in response to
noradrenaline three times" after "response to noradrenaline".
Page 117, line 16 insert "Arylazido Aminopropionyl Adenosine Triphosphate" 
after "ANAPP/.
Page 119 Insert "than Guinea Pig Portal Vein" after "Rat Anococcygeus" in the 
title.
Page 122, line 21 insert "12-0-tetraecanoylphorbol- 13-acetate" before 'TPA". 
Page 143 "1M nifedipine" should read "1/iM nifedipine".
Page 164, line 12 "Prestronk and Drachman" should read "Pestronk and 
Drachman".
Page 171, Bers, 1980 reference date should be 1982.
Page 176, Gilkey et al, 1987 reference "oryzias latipes" should read "Oiyzias 
latipes".
Page 181, Miller, 1975 reference should read "Miller D.J. (1985)".
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